US20200315854A1 - Dressings, systems and methods for treating a tissue site - Google Patents
Dressings, systems and methods for treating a tissue site Download PDFInfo
- Publication number
- US20200315854A1 US20200315854A1 US16/910,421 US202016910421A US2020315854A1 US 20200315854 A1 US20200315854 A1 US 20200315854A1 US 202016910421 A US202016910421 A US 202016910421A US 2020315854 A1 US2020315854 A1 US 2020315854A1
- Authority
- US
- United States
- Prior art keywords
- layer
- dressing
- liquid
- pressure
- reduced
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title abstract description 8
- 239000012530 fluid Substances 0.000 claims abstract description 42
- 239000000463 material Substances 0.000 claims description 19
- 239000007788 liquid Substances 0.000 claims description 17
- 230000008878 coupling Effects 0.000 claims description 4
- 238000010168 coupling process Methods 0.000 claims description 4
- 238000005859 coupling reaction Methods 0.000 claims description 4
- 230000001939 inductive effect Effects 0.000 claims description 4
- 125000006850 spacer group Chemical group 0.000 abstract description 26
- 239000006260 foam Substances 0.000 abstract description 14
- 239000010410 layer Substances 0.000 description 115
- 210000001519 tissue Anatomy 0.000 description 41
- 230000003187 abdominal effect Effects 0.000 description 26
- 238000007789 sealing Methods 0.000 description 19
- 210000000683 abdominal cavity Anatomy 0.000 description 12
- 230000008901 benefit Effects 0.000 description 5
- 210000002615 epidermis Anatomy 0.000 description 4
- 206010052428 Wound Diseases 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- -1 open-cell Polymers 0.000 description 3
- 230000002093 peripheral effect Effects 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 206010003445 Ascites Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 239000012790 adhesive layer Substances 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- 239000000560 biocompatible material Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 239000004814 polyurethane Substances 0.000 description 2
- 229920002635 polyurethane Polymers 0.000 description 2
- 238000003466 welding Methods 0.000 description 2
- 229920001247 Reticulated foam Polymers 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000004568 cement Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000002706 hydrostatic effect Effects 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000002262 irrigation Effects 0.000 description 1
- 238000003973 irrigation Methods 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 229920006254 polymer film Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
Images
Classifications
-
- A61F13/05—
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/00051—Accessories for dressings
- A61F13/00068—Accessories for dressings specially adapted for application or removal of fluid, e.g. irrigation or drainage of wounds, under-pressure wound-therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/00004—Non-adhesive dressings
- A61F13/00021—Non-adhesive dressings characterized by the structure of the dressing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/00004—Non-adhesive dressings
- A61F13/00021—Non-adhesive dressings characterized by the structure of the dressing
- A61F13/00029—Non-adhesive dressings characterized by the structure of the dressing made of multiple layers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/00987—Apparatus or processes for manufacturing non-adhesive dressings or bandages
- A61F13/00991—Apparatus or processes for manufacturing non-adhesive dressings or bandages for treating webs, e.g. for moisturising, coating, impregnating or applying powder
- A61F13/00995—Apparatus or processes for manufacturing non-adhesive dressings or bandages for treating webs, e.g. for moisturising, coating, impregnating or applying powder for mechanical treatments
-
- A61F13/01021—
-
- A61F13/01029—
-
- A61M1/0088—
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/90—Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing
- A61M1/91—Suction aspects of the dressing
- A61M1/915—Constructional details of the pressure distribution manifold
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/90—Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing
- A61M1/91—Suction aspects of the dressing
- A61M1/916—Suction aspects of the dressing specially adapted for deep wounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00089—Wound bandages
- A61F2013/0017—Wound bandages possibility of applying fluid
- A61F2013/00174—Wound bandages possibility of applying fluid possibility of applying pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00089—Wound bandages
- A61F2013/00314—Wound bandages with surface treatments
- A61F2013/00327—Wound bandages with surface treatments to create projections or depressions in surface
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00365—Plasters use
- A61F2013/00412—Plasters use for use with needles, tubes or catheters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00365—Plasters use
- A61F2013/00536—Plasters use for draining or irrigating wounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00365—Plasters use
- A61F2013/0054—Plasters use for deep wounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/90—Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing
- A61M1/92—Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing with liquid supply means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/90—Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing
- A61M1/98—Containers specifically adapted for negative pressure wound therapy
- A61M1/982—Containers specifically adapted for negative pressure wound therapy with means for detecting level of collected exudate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/10—Trunk
- A61M2210/1021—Abdominal cavity
Definitions
- the present disclosure relates generally to medical treatment systems, and more particularly, to apparatuses, systems, and methods for treating tissue sites using reduced pressure.
- reduced pressure may be used for, among other things, reduced-pressure therapy to encourage granulation at a tissue site or for draining fluids at a tissue site.
- reduced-pressure therapy to encourage granulation at a tissue site or for draining fluids at a tissue site.
- “or” does not require mutual exclusivity. Both reduced-pressure therapy and drainage with reduced pressure often involve manifolding, or distributing, reduced pressure to the tissue site.
- a dressing for distributing reduced pressure to a tissue site includes a plurality of liquid-impermeable layers that are stacked and a plurality of spacers disposed at least partially between adjacent liquid-impermeable layers.
- the plurality of liquid-impermeable layers are fenestrated.
- the plurality of spacers and plurality of liquid-impermeable layers form a plurality of flow paths for allowing fluid flow under reduced pressure.
- Adjacent layers of the plurality of liquid-impermeable layers may be stacked without foam between at least a majority of coextensive surfaces.
- a system for distributing reduced pressure to a tissue site includes a reduced-pressure source, a reduced-pressure delivery conduit, and a reduced-pressure dressing.
- the reduced-pressure delivery conduit fluidly couples the reduced-pressure source and the reduced-pressure dressing.
- the reduced-pressure dressing includes a plurality of liquid-impermeable layers that are stacked and a plurality of spacers disposed at least partially between liquid-impermeable layers.
- the plurality of liquid-impermeable layers are fenestrated.
- the plurality of spacers and plurality of liquid-impermeable layers form a plurality of flow paths for allowing fluid flow under reduced pressure. Adjacent layers of the plurality of liquid-impermeable layers may be stacked without foam between at least a majority of coextensive surfaces.
- a method of manufacturing a dressing for distributing reduced pressure to a tissue site includes the steps of: providing a plurality of liquid-impermeable layers, stacking the plurality of liquid-impermeable layers, and forming a plurality of spacers disposed at least partially between adjacent liquid-impermeable layers.
- the plurality of liquid-impermeable layers are fenestrated.
- the plurality of spacers and plurality of liquid-impermeable layers form a plurality of flow paths for allowing fluid flow under reduced pressure. Adjacent layers of the plurality of liquid-impermeable layers are stacked without foam between at least a majority of coextensive surfaces.
- a method for delivering reduced pressure to a tissue site includes the steps of: providing a reduced-pressure dressing, deploying the reduced-pressure dressing adjacent to the tissue site, fluidly coupling a reduced-pressure source to the reduced-pressure dressing, and activating the reduced-pressure source.
- the reduced-pressure dressing includes a plurality of liquid-impermeable layers that are stacked and a plurality of spacers disposed at least partially between adjacent liquid-impermeable layers.
- the plurality of liquid-impermeable layers are fenestrated.
- the plurality of spacers and plurality of liquid-impermeable layers form a plurality of flow paths for allowing fluid flow under reduced pressure. Adjacent layers of the plurality of liquid-impermeable layers may be stacked without foam between at least a majority of coextensive surfaces.
- FIG. 1 is a schematic diagram with a portion shown in cross section of an illustrative embodiment of a reduced-pressure treatment system for treating an abdominal cavity;
- FIG. 2 is a schematic, perspective view of an illustrative dressing for use with reduced pressure
- FIG. 3 is a schematic cross section of a portion of the illustrative dressing of FIG. 2 shown without reduced pressure applied;
- FIG. 4 is a schematic cross section of the portion of the illustrative dressing of FIG. 3 shown with reduced pressure applied;
- FIG. 5 is a schematic diagram showing various flow paths in an illustrative embodiment of a dressing for use with reduced pressure
- FIG. 6 is a schematic cross section of a portion of an illustrative dressing for use with reduced pressure
- FIG. 7 is a schematic diagram with a portion shown in cross section of an illustrative embodiment of a reduced-pressure treatment system for treating a wound
- FIG. 8 is a schematic cross section of a portion of an illustrative dressing for use with reduced pressure
- FIG. 9 is a schematic cross section of a portion of an illustrative dressing for use with reduced pressure showing a fold
- FIG. 10 is a schematic cross section of a portion of an illustrative dressing for use with reduced pressure
- FIG. 11 is a schematic, perspective view of a generic curved body part or a portion of a curved body part
- FIG. 12 is a schematic, perspective view of an illustrative dressing for use with reduced pressure shown in a flat arrangement
- FIG. 13 is a schematic, perspective view of the illustrative dressing of FIG. 12 shown applied to the curved body part of FIG. 11 ;
- FIG. 14 is a schematic, perspective view with a portion shown in cross section of a fold in the illustrative dressing of FIG. 13 ;
- FIG. 15 is a schematic, cross section of a fold in the illustrative dressing of FIG. 14 taken along line 15 - 15 ;
- FIG. 16 is a schematic, perspective view of an illustrative dressing for use with reduced pressure showing illustrative flow channels
- FIG. 17 is a schematic, perspective view of an illustrative dressing for use with reduced pressure showing an illustrative liquid-delivery channel.
- FIG. 18 is schematic, perspective view of a portion of the illustrative dressing of FIG. 17 showing the peripheral edge of the illustrative liquid-delivery channel.
- the abdominal treatment device 104 may be, for example, an illustrative dressing 200 for use with reduced pressure as shown in FIG. 2 .
- the system 100 and the abdominal treatment device 104 are for treating a tissue site 106 of a patient.
- the tissue site 106 may be the bodily tissue of any human, animal, or other organism, including bone tissue, adipose tissue, muscle tissue, dermal tissue, connective tissue, cartilage, tendons, ligaments, or any other tissue.
- the tissue site 106 includes tissue in a body cavity, and in particular the abdominal cavity 102 , and includes abdominal contents 108 or tissue that is proximate the abdominal cavity 102 .
- Treatment of the tissue site 106 may include removal of fluids, e.g., ascites, protection of the abdominal cavity 102 , or reduced-pressure therapy.
- the abdominal treatment device 104 is disposed within the abdominal cavity 102 of the patient to treat the tissue site 106 .
- the abdominal treatment device 104 is supported by the abdominal contents 108 .
- the abdominal contents 108 make up a surface on which the abdominal treatment device 104 is placed.
- a portion 110 of the abdominal treatment device 104 may be placed in or proximate to a first paracolic gutter 112 , and another portion 114 may be placed in or proximate to a second paracolic gutter 116 .
- FIG. 1 is a schematic drawing and is not to scale and the density of flow paths would typically be higher.
- the abdominal treatment device 104 is formed with a plurality of liquid-impermeable layers 117 , e.g., a first liquid-impermeable layer 118 and a second liquid-impermeable layer 120 .
- the plurality of liquid-impermeable layers 117 e.g., layers 118 , 120 , are formed with fenestrations 122 , 124 , respectively.
- “Liquid impermeable” with respect to “liquid-impermeable layers” means that the layers are formed with a liquid-impermeable material.
- the layer may be liquid permeable when fenestrated, but nonetheless is referred to as a liquid-impermeable layer.
- the fenestrations 122 , 124 may take any shape, e.g., circular apertures, rectangular openings, or polygons.
- the fenestrations 122 , 124 are presented in this illustrative embodiment as slits, or linear cuts. Not every layer need be fenestrated.
- the abdominal treatment device 104 has a first side 105 and a second, tissue-facing side 107 .
- the abdominal treatment device 104 is typically symmetrical such that the sides 105 , 107 are same. Reference to different sides, however, is made for explanation purposes.
- a manifold 126 or manifold pad, distributes reduced pressure to the abdominal treatment device 104 .
- a sealing member 128 provides a fluid seal over the abdominal cavity 102 .
- One or more skin closure devices may be placed on a patient's epidermis 130 .
- a reduced-pressure connector subsystem 132 may be used to fluidly couple the abdominal treatment device 104 to a reduced-pressure delivery conduit 134 .
- the reduced-pressure connector subsystem 132 may include a reduced-pressure connector 136 , or interface, and the manifold 126 .
- the reduced-pressure connector subsystem 132 may be an in situ connector (not shown) on the abdominal treatment device 104 or any other device for supplying reduced pressure to the abdominal treatment device 104 .
- the reduced-pressure delivery conduit 134 is fluidly coupled to a reduced-pressure source 137 .
- reduced pressure is delivered to the abdominal treatment device 104 through the manifold 126 which receives reduced pressure through the reduced-pressure connector 136 , which is coupled to the reduced-pressure delivery conduit 134 .
- the reduced-pressure source 137 delivers reduced pressure to the reduced-pressure delivery conduit 134 .
- the reduced pressure may be applied to the tissue site 106 to help promote removal of ascites, exudates, or other fluids from the tissue site 106 .
- reduced pressure may be applied to stimulate the growth of additional tissue.
- only fluid removal may be desired.
- reduced pressure generally refers to a pressure less than the ambient pressure at a tissue site that is being subjected to treatment. In most cases, this reduced pressure will be less than the atmospheric pressure at which the patient is located. Alternatively, the reduced pressure may be less than a hydrostatic pressure at the tissue site.
- the manifold 126 is shown adjacent to the abdominal treatment device 104 .
- the manifold 126 may take many forms.
- the term “manifold” as used herein generally refers to a substance or structure that is provided to assist in applying reduced pressure to, delivering fluids to, or removing fluids from the tissue site 106 directly or via the abdominal treatment device 104 .
- the manifold 126 typically includes a plurality of flow channels or pathways that distribute the fluids provided to and removed from the tissue site 106 around the manifold 126 and through the abdominal treatment device 104 .
- the flow channels or pathways are interconnected to improve distribution of fluids provided or removed.
- the manifold 126 may be a biocompatible material that is capable of being placed in contact with the tissue site 106 and distributing reduced pressure to the tissue site 106 or abdominal treatment device 104 .
- manifold 126 may include, without limitation, devices that have structural elements arranged to form flow channels, cellular foam, such as open-cell foam, porous tissue collections, liquids, gels and foams that include or cure to include flow channels.
- the manifold 126 may be porous and may be made from foam, gauze, felted mat, or any other material suited to a particular biological application.
- the manifold 126 is a porous foam and includes a plurality of interconnected cells or pores that act as flow channels.
- the porous foam may be a polyurethane, open-cell, reticulated foam, such as a GranuFoam® material manufactured by Kinetic Concepts, Incorporated of San Antonio, Texas. Other embodiments may include “closed cells.”
- the manifold 126 may also be used to distribute fluids, such as medications, antibacterials, growth factors, and various solutions.
- Other layers may be included in or on the manifold 126 , such as absorptive materials, wicking materials, hydrophobic materials, and hydrophilic materials.
- the sealing member 128 is placed over the abdominal cavity 102 and provides a fluid seal.
- fluid seal or “seal,” means a seal adequate to maintain reduced pressure at a desired site given the particular reduced-pressure source or subsystem involved.
- the sealing member 128 may be a cover, or drape, that is used to secure the manifold 126 on a portion of the abdominal treatment device 104 .
- the sealing member 128 may be impermeable or semi-permeable.
- the sealing member 128 is capable of maintaining reduced pressure at the tissue site 106 or other desired location after installation of the sealing member 128 over the abdominal cavity 102 and particularly an abdominal cavity opening 140 .
- the sealing member 128 may be a flexible over-drape or film formed from a silicone-based compound, acrylic, hydrogel or hydrogel-forming material, polyurethane, polymer film, or any other biocompatible material that includes the impermeability or permeability characteristics as desired for applying reduced pressure to the tissue site 106 .
- the sealing member 128 may further include an attachment device 142 to couple the sealing member 128 to the patient's epidermis 130 .
- the attachment device 142 may take many forms.
- the attachment device 142 may be an adhesive layer 144 that may be positioned along a perimeter of the sealing member 128 or any portion of the sealing member 128 to provide, directly or indirectly, a fluid seal with the patient's epidermis 130 .
- the adhesive layer 144 may also be pre-applied to the sealing member 128 and covered with a releasable backing, or member (not shown), that is removed at the time of application.
- the reduced-pressure connector 136 may be, as one example, a port or connector, which permits the passage of fluid from the manifold 126 to the reduced-pressure delivery conduit 134 and vice versa. For example, fluid collected from the tissue site 106 using the manifold 126 and the abdominal treatment device 104 may enter the reduced-pressure delivery conduit 134 via the reduced-pressure connector 136 . In another embodiment, the system 100 may omit the reduced-pressure connector 136 and the reduced-pressure delivery conduit 134 may be inserted directly into the sealing member 128 and into the manifold 126 .
- the reduced-pressure delivery conduit 134 may be a medical conduit or tubing or any other means for transportating a reduced pressure and fluid.
- the reduced-pressure delivery conduit 134 may be a multi-lumen member for readily delivering reduced pressure and removing fluids.
- the reduced-pressure delivery conduit 134 is a two-lumen conduit with one lumen for reduced pressure and liquid transport and one lumen for communicating pressure to a pressure sensor.
- Reduced pressure is generated and supplied to the reduced-pressure delivery conduit 134 by the reduced-pressure source 137 .
- a wide range of reduced pressures may be generated or supplied by the reduced-pressure source 137 .
- the reduced pressure is in the range of ⁇ 50 to ⁇ 300 mm Hg and in another illustrative embodiment, the range may include ⁇ 100 mm Hg to ⁇ 200 mm Hg.
- the pressure may be, for example, ⁇ 100, ⁇ 110, ⁇ 120, ⁇ 125, ⁇ 130, ⁇ 140, ⁇ 150, ⁇ 160, ⁇ 170, ⁇ 180, ⁇ 190, or ⁇ 200 mm Hg.
- the reduced-pressure source 137 includes preset selectors for ⁇ 100 mm Hg, ⁇ 125 mm Hg, and ⁇ 150 mm Hg.
- the reduced-pressure source 137 may also include a number of alarms, such as a blockage alarm, a leakage alarm, canister full alarm, or a battery-low alarm.
- the reduced-pressure source 137 may be a portable source, wall source, or other unit for abdominal cavities or other tissue sites.
- the reduced-pressure source 137 may selectively deliver a constant pressure, varied pressure, intermittent pressure, or continuous pressure.
- the fluid removed from the abdominal cavity 102 through the reduced-pressure delivery conduit 134 could be as much as 5 L or more per day depending on the circumstances.
- a fluid reservoir is typically associated with the reduced-pressure source 137 for receiving fluids.
- a number of different devices may be added to a portion of the reduced-pressure delivery conduit 134 .
- the device 146 may be a fluid reservoir, or canister collection member, a pressure-feedback device, a volume detection system, a blood detection system, an infection detection system, a filter, a port with a filter, a flow monitoring system, a temperature monitoring system, etc.
- Multiple devices 146 may be included. Some of these devices, e.g., the fluid collection member, may be formed integrally to the reduced-pressure source 137 .
- the dressing 200 may be a modular component used in systems or devices.
- the dressing 200 may be used as the abdominal treatment device 104 of FIG. 1 or as the manifold member 302 in FIG. 7 .
- the dressing 200 includes a plurality of liquid-impermeable layers 202 , such as a first liquid-impermeable layer 204 and a second liquid-impermeable layer 206 , and a plurality of spacers 208 .
- the plurality of liquid-impermeable layers 202 may include fenestrations 203 , which may be formed with any shape and size.
- the fenestrations 203 allow the egress of reduced pressure and the ingress of fluids.
- the plurality of liquid-impermeable layers 202 may be formed from numerous materials including the materials used for the sealing member 128 of FIG. 1 .
- the plurality of spacers 208 may be disposed (including formed or positioned) at least partially between adjacent members of the plurality of liquid-impermeable layers 202 . “Partially” means to some extent or degree.
- the plurality of spacers 208 may be formed by portions of the impermeable layers themselves bonded to hold portions of adjacent layers with a relative displacement or may be formed by the layers being folded or in other ways as shown and described herein.
- Reference to spacers “between” layers means the portions displacing the layers or portions of the layers are at least partially located between the exterior of adjacent layers. For example, a fold has a curved portions between the exteriors of two layers that may be formed from a single layer of material.
- the spacer may be said to be between layers even when formed by portions of the layers.
- the plurality of spacers 208 provide areas of separation between adjacent members of the plurality of liquid-impermeable layers 202 and thereby help create a plurality of flow paths 210 .
- the figures are not to scale, and it should be understood that the flow paths 210 may be much more dense than shown.
- the flow paths 210 may be only one millimeter apart, two millimeters apart, three millimeters apart, four millimeters a part, or another dimension.
- the plurality of spacers 208 and plurality of liquid-impermeable layers 202 form the plurality of flow paths 210 for allowing fluid flow under reduced pressure or positive pressure.
- Adjacent layers of the plurality of liquid-impermeable layers 202 are typically stacked. “Stacked” generally means disposing or forming layers to be adjacent.
- foam or other material with flow paths may be included between the liquid-impermeable layers 202 .
- the first liquid-impermeable layer 204 and the second liquid-impermeable layer 206 may share an area A 1 and the foam may have an area A 2 that is in the range of 0% to 50% of A 1 and often includes no foam (i.e., 0% A 1 ).
- the plurality of spacers 208 may be formed in numerous ways including by forming a plurality of bonds 212 at a plurality of bond sites 214 .
- the plurality of bonds 212 may be formed using any known technique, including without limitation welding (e.g., ultrasonic or RF welding), chemical bonding, adhesives, or cements.
- the plurality of bond sites 214 may be random or may have a spaced pattern.
- the plurality of bonds 212 may have a longitudinal dimension, a lateral dimension, and a vertical dimension (for the orientation shown).
- the plurality of bonds 212 may have an aspect ratio (longitudinal dimension/lateral dimension) greater than 3, or greater than 6, or greater still.
- the plurality of bonds 212 may also be circular in nature or any other shape.
- FIG. 3 a detail of a portion of the dressing 200 of FIG. 2 is presented.
- the dressing 200 is shown without reduced pressure applied.
- FIG. 4 shows the same detail as FIG. 3 , but with reduced pressure applied.
- the reduced pressure may draw portions of the adjacent members of the plurality of liquid-impermeable layers 202 closer together, but at least a portion of the plurality of flow paths 210 continue to provide a flow path that may transport reduced pressure and fluids.
- a reduced-pressure aperture 216 delivers reduced pressure between adjacent layers of the plurality of liquid-impermeable layers 202 and pulls or urges liquid through fenestrations 203 from a tissue site or cavity and then along the plurality of flow paths 210 ( FIG. 3 ) to allow flows streams 218 to reach the reduced-pressure aperture 216 .
- the dressing 200 is shown with the plurality of liquid-impermeable layers 202 including the first liquid-impermeable layer 204 , a second liquid-impermeable layer 206 , and a third liquid-impermeable layer 207 .
- the fenestrations 203 may or may not be through the third liquid-impermeable layer 207 . In other words, some layers, e.g., third liquid-impermeable layer 207 may not be fenestrated. Additional layers may be added to the plurality of liquid-impermeable layers 202 .
- the spacers 208 provide at least some separation between adjacent layers of the plurality of liquid-impermeable layers 202 to define flow paths 210 .
- a reduced-pressure treatment system 300 that includes a manifold member 302 .
- the manifold member 302 may be the dressing 200 of FIG. 2 .
- the reduced-pressure treatment system 300 provides reduced pressure to a tissue site 304 , such as an open wound 306 .
- the wound 306 may extend through epidermis 308 and into subcutaneous tissue 310 .
- the manifold member 302 is placed adjacent to the tissue site 304 and then is covered with a sealing member 312 .
- An attachment device 314 may be used to help provide a fluid seal over the tissue site 304 .
- a connector subsystem 316 may fluidly couple a reduced-pressure delivery conduit 318 and the manifold member 302 .
- the reduced-pressure delivery conduit 318 is also fluidly coupled to a reduced-pressure source 320 .
- a device 322 may be fluidly coupled or otherwise associated with the reduced-pressure delivery conduit 318 .
- the device 322 is the same or analogous to the device 146 of FIG. 1 . Moreover, many of the components of the system 300 of FIG. 3 are identical or analogous to components of the system 100 of FIG. 1 . As another example, the sealing member 312 is analogous to the sealing member 128 . The attachment device 314 is analogous to the attachment device 142 of FIG. 1 .
- the manifold member 302 is placed adjacent to the tissue site 304 .
- the sealing member 312 is applied over the tissue site 304 and a fluid seal is thereby formed.
- the reduced-pressure connector subsystem 316 is applied to the sealing member 312 .
- the reduced-pressure delivery conduit 318 is fluidly coupled to the reduced-pressure connector subsystem 316 and to the reduced-pressure source 320 .
- the reduced-pressure source 320 is activated.
- the reduced pressure is communicated to the manifold member 302 and causes reduced pressure to be delivered to the tissue site 304 through a plurality of flow paths (see flow paths 210 in FIG. 2 ) and fenestrations (see fenestrations 203 in FIG. 2 ).
- micro-stress-inducing elements may be added to the tissue-facing side of the manifold member 302 to promote granulation.
- the micro-stress-inducing elements may include small buttons, projecting columns, or other devices.
- the dressing 400 includes a plurality of liquid-impermeable layers 402 , e.g., a first liquid-impermeable layer 404 , a second liquid-impermeable layer 406 , and a third liquid-impermeable layer 408 .
- the plurality of liquid-impermeable layers 402 is fenestrated with fenestrations 403 .
- the plurality of liquid-impermeable layers 402 are formed with thickness variations or enlarged portions 410 that form spacers 412 . Under reduced pressure, the spacers 412 continue to provide a plurality of flow paths 414 .
- the plurality of flow paths 414 function analogously to flow paths 210 of FIG. 2 .
- the dressing 500 is formed with a plurality of liquid-impermeable layers 502 .
- the plurality of liquid-impermeable layers 502 are formed by doubling, or folding, a first liquid-impermeable layer 504 over on itself to form a first portion 506 and a second portion 508 .
- the plurality of liquid-impermeable layers 502 is fenestrated (not explicitly shown but analogous to fenestrations 403 in FIG. 8 ).
- a fold 510 has a curved portion 511 with a radius 512 .
- the dressing 500 may have a plurality of folds, such as fold 510 .
- the folds, e.g., 510 serve as spacers.
- the radius 512 is relatively larger when thicker materials or more rigid materials are used for the plurality of liquid-impermeable layers 502 .
- the radius 512 forms a micro-channel 520 , which may be one of a plurality of flow paths 518 .
- the first liquid-impermeable layer 504 may be formed with enlarged portions, e.g., enlarged portions 514 and 516 that help define the plurality of flow paths 518 .
- the radius 512 may also form or help form one of the flow paths 518 .
- the flow paths 518 may be formed by a plurality of enlarged portions, e.g., enlarged portions 514 , 516 , or a plurality of folds, e.g., the fold 510
- FIG. 10 shows the dressing 500 of FIG. 9 , but a plurality of bonds 524 has been added at a plurality of bond sites 526 .
- the flow paths 518 may be formed in dressing 500 by folding the first liquid-impermeable layer 504 on itself, stretching either the first portion 506 relative to the second portion 508 (or vice versa) and then adding the plurality of bonds 524 . Once bonded, the portion of the first liquid-impermeable layer 504 in tension may be released. This release will then form a plurality of flow paths 518 between the plurality of bonds 524 .
- the dressing 600 may be used with numerous reduced-pressure systems, such as in the system 100 of FIG. 1 as the abdominal treatment device 104 , or in the system 300 of FIG. 3 as the manifold member 302 .
- the dressing 600 creates folds 608 by requiring a two-dimensional flat layer 602 to form to a three-dimensional body part, or curved body part 606 .
- the folds 608 comprise channels, or flow paths 612 .
- the folds 608 of the dressing 600 facilitate fluid movement.
- the dressing 600 is formed with the two-dimensional flat layer 602 , or liquid-impermeable layer 602 .
- the liquid-impermeable layer 602 has fenestrations 604 .
- the fenestrations 604 allow the egress of reduced pressure and the ingress of fluids.
- the liquid-impermeable layer 602 may be formed from any suitable material, such as those mentioned in connection with the liquid-impermeable layers 118 , 120 , 204 , and 206 of FIGS. 1 and 2 .
- the liquid-impermeable layer 602 may be single ply, double ply, or multi-ply. As shown in FIG.
- the dressing 600 may be formed as a flat oval, but other shapes, e.g., a circle, square, or irregular shape, may be used. While referenced as a two-dimensional flat layer 602 , the two-dimensional flat layer 602 will have some thickness but will rest flat on a flat surface.
- the dressing 600 is for use with the curved body part 606 .
- the curved body 606 may be any part of a patient that is not flat and that typically has a substantial curvature.
- the folds 608 or plurality of folds, are created.
- the plurality of folds 608 that develop in order for the dressing 600 to rest flush against the curved body part 606 , create the channels or flow paths 612 .
- the folds 608 comprise a plurality of spacers 610 that provide areas of separation between portions of the liquid-impermeable layer 602 to define the plurality of flow paths 612 .
- the flow paths 612 may function as micro-channels that facilitate fluid movement.
- FIG. 14 a perspective view of one of the plurality of folds 608 of the dressing 600 is shown.
- the liquid-impermeable layer 602 is a single-ply layer and two folds 608 are shown.
- the liquid-impermeable layer 602 may be a multi-layer member.
- the folds 608 comprise spacers 610 and the resultant openings of the folds serve as the micro-channels.
- FIG. 15 presents a cross section of the portion of the dressing 600 shown in FIG. 14 .
- FIG. 16 another illustrative embodiment of a dressing 700 is presented that may be used with numerous reduced-pressure systems, such as systems 100 and 300 of FIGS. 1 and 3 .
- the dressing 700 may be formed with a plurality of liquid-impermeable layers 702 that have fenestrations 704 .
- a plurality of spacers e.g., spacers 208 of FIG. 2 , may be formed between adjacent layers of the plurality of liquid-impermeable layers 702 to form a plurality of flow paths (not shown but analogous to the flow paths 210 of FIG. 2 ).
- a plurality of longitudinal members or bonds 706 may be formed on the plurality of liquid-impermeable layers 702 to form a plurality of flow channels 708 .
- a first longitudinal bond 710 and a second longitudinal bond 712 which is spaced from the first longitudinal bond 710 , form a flow channel 714 .
- a first side 716 may be formed with a reduced-pressure aperture 718 to facilitate fluidly coupling a reduced-pressure source (not shown).
- the flow channels 708 direct fluid flowing in flow paths along directed areas of the dressing 700 .
- the dressing 800 may be formed with a plurality of liquid-impermeable layers 802 .
- the plurality of liquid-impermeable layers 802 may have fenestrations 804 and may be bonded at bonded sites analogous to bonds 212 at bond sites 214 in FIG. 2 .
- the dressing 800 may include a liquid-delivery channel 806 .
- the liquid-delivery channel 806 may include a first portion 808 .
- the first portion 808 is part of a first liquid-impermeable layer 810 of the plurality of liquid-impermeable layers 802 , but without fenestrations 804 .
- the liquid-delivery channel 806 also includes a second portion 812 .
- the second portion 812 is part of a second liquid-impermeable layer 814 of the plurality of liquid-impermeable layers 802 , and again the second liquid-impermeable layer 814 has no fenestrations 804 .
- a channel-forming bond 816 is formed that couples the first portion 808 and the second portion 812 to form a liquid delivery path 818 .
- a liquid aperture 820 may be formed on the first liquid-impermeable layer 810 to facilitate fluidly coupling of a liquid-supply source (not shown) to the liquid-delivery channel 806 .
- the dressing 800 is deployed as part of a reduced-pressure treatment system proximate the tissue site to be treated.
- a reduced-pressure source (not shown) is fluidly coupled to a reduced-pressure aperture 822 to provide reduced pressure to the dressing 800 .
- the reduced pressure pulls fluids into the dressing 800 except for the liquid-delivery channel 806 .
- a fluid-supply source (not shown) is fluidly coupled to the liquid aperture 820 .
- Liquid e.g., a saline irrigation fluid or medicine, is delivered to the liquid aperture 820 .
- liquid delivered to the liquid aperture 820 is urged through the liquid delivery path 818 toward the peripheral edge 824 and exits the liquid delivery channel 806 as suggested by arrows 826 and 828 in FIG. 17 .
- the fluid exiting 828 is pulled through a second portion 830 of the dressing 800 through the fenestrations 804 and toward the reduced-pressure aperture 822 .
- the liquid-delivery channel 806 may be used to irrigate, supply medicines, or other purposes.
Abstract
Dressings, systems, and methods are disclosed for treating tissue with reduced pressure. A dressing for distributing reduced pressure to a tissue site includes a plurality of liquid-impermeable layers that are stacked and a plurality of spacers disposed at least partially between adjacent liquid-impermeable layers. The plurality of liquid-impermeable layers are fenestrated at least in part. The plurality of spacers and plurality of liquid-impermeable layers form a plurality of flow paths for allowing fluid flow under reduced pressure. Adjacent layers of the plurality of liquid-impermeable layers are stacked without foam between at least a majority of coextensive surfaces. Other dressings, systems, and methods are disclosed.
Description
- This application is a divisional of U.S. patent application Ser. No. 15/479,013, filed Apr. 4, 2017, which is a continuation of U.S. patent application Ser. No. 14/230,487, filed Mar. 31, 2014, now U.S. Pat. No. 9,642,953, which is a continuation of U.S. patent application Ser. No. 13/043,315, filed Mar. 8, 2011, now U.S. Pat. No. 8,721,606, which claims the benefit, under 35 USC § 119(e), of the filing of U.S. Provisional Patent Application No. 61/312,968, entitled “Dressings, Systems, and Methods for Treating a Tissue Site,” filed Mar. 11, 2010, which are incorporated herein by reference for all purposes.
- The present disclosure relates generally to medical treatment systems, and more particularly, to apparatuses, systems, and methods for treating tissue sites using reduced pressure.
- Depending on the medical circumstances, reduced pressure may be used for, among other things, reduced-pressure therapy to encourage granulation at a tissue site or for draining fluids at a tissue site. As used herein, unless otherwise indicated, “or” does not require mutual exclusivity. Both reduced-pressure therapy and drainage with reduced pressure often involve manifolding, or distributing, reduced pressure to the tissue site.
- According to a non-limiting, illustrative embodiment, a dressing for distributing reduced pressure to a tissue site includes a plurality of liquid-impermeable layers that are stacked and a plurality of spacers disposed at least partially between adjacent liquid-impermeable layers. The plurality of liquid-impermeable layers are fenestrated. The plurality of spacers and plurality of liquid-impermeable layers form a plurality of flow paths for allowing fluid flow under reduced pressure. Adjacent layers of the plurality of liquid-impermeable layers may be stacked without foam between at least a majority of coextensive surfaces.
- According to another non-limiting, illustrative embodiment, a system for distributing reduced pressure to a tissue site includes a reduced-pressure source, a reduced-pressure delivery conduit, and a reduced-pressure dressing. The reduced-pressure delivery conduit fluidly couples the reduced-pressure source and the reduced-pressure dressing. The reduced-pressure dressing includes a plurality of liquid-impermeable layers that are stacked and a plurality of spacers disposed at least partially between liquid-impermeable layers. The plurality of liquid-impermeable layers are fenestrated. The plurality of spacers and plurality of liquid-impermeable layers form a plurality of flow paths for allowing fluid flow under reduced pressure. Adjacent layers of the plurality of liquid-impermeable layers may be stacked without foam between at least a majority of coextensive surfaces.
- According to another non-limiting, illustrative embodiment, a method of manufacturing a dressing for distributing reduced pressure to a tissue site includes the steps of: providing a plurality of liquid-impermeable layers, stacking the plurality of liquid-impermeable layers, and forming a plurality of spacers disposed at least partially between adjacent liquid-impermeable layers. The plurality of liquid-impermeable layers are fenestrated. The plurality of spacers and plurality of liquid-impermeable layers form a plurality of flow paths for allowing fluid flow under reduced pressure. Adjacent layers of the plurality of liquid-impermeable layers are stacked without foam between at least a majority of coextensive surfaces.
- According to another non-limiting, illustrative embodiment, a method for delivering reduced pressure to a tissue site includes the steps of: providing a reduced-pressure dressing, deploying the reduced-pressure dressing adjacent to the tissue site, fluidly coupling a reduced-pressure source to the reduced-pressure dressing, and activating the reduced-pressure source. The reduced-pressure dressing includes a plurality of liquid-impermeable layers that are stacked and a plurality of spacers disposed at least partially between adjacent liquid-impermeable layers. The plurality of liquid-impermeable layers are fenestrated. The plurality of spacers and plurality of liquid-impermeable layers form a plurality of flow paths for allowing fluid flow under reduced pressure. Adjacent layers of the plurality of liquid-impermeable layers may be stacked without foam between at least a majority of coextensive surfaces.
- Other features and advantages of the illustrative embodiments will become apparent with reference to the drawings and detailed description that follow.
-
FIG. 1 is a schematic diagram with a portion shown in cross section of an illustrative embodiment of a reduced-pressure treatment system for treating an abdominal cavity; -
FIG. 2 is a schematic, perspective view of an illustrative dressing for use with reduced pressure; -
FIG. 3 is a schematic cross section of a portion of the illustrative dressing ofFIG. 2 shown without reduced pressure applied; -
FIG. 4 is a schematic cross section of the portion of the illustrative dressing ofFIG. 3 shown with reduced pressure applied; -
FIG. 5 is a schematic diagram showing various flow paths in an illustrative embodiment of a dressing for use with reduced pressure; -
FIG. 6 is a schematic cross section of a portion of an illustrative dressing for use with reduced pressure; -
FIG. 7 is a schematic diagram with a portion shown in cross section of an illustrative embodiment of a reduced-pressure treatment system for treating a wound; -
FIG. 8 is a schematic cross section of a portion of an illustrative dressing for use with reduced pressure; -
FIG. 9 is a schematic cross section of a portion of an illustrative dressing for use with reduced pressure showing a fold; -
FIG. 10 is a schematic cross section of a portion of an illustrative dressing for use with reduced pressure; -
FIG. 11 is a schematic, perspective view of a generic curved body part or a portion of a curved body part; -
FIG. 12 is a schematic, perspective view of an illustrative dressing for use with reduced pressure shown in a flat arrangement; -
FIG. 13 is a schematic, perspective view of the illustrative dressing ofFIG. 12 shown applied to the curved body part ofFIG. 11 ; -
FIG. 14 is a schematic, perspective view with a portion shown in cross section of a fold in the illustrative dressing ofFIG. 13 ; -
FIG. 15 is a schematic, cross section of a fold in the illustrative dressing ofFIG. 14 taken along line 15-15; -
FIG. 16 is a schematic, perspective view of an illustrative dressing for use with reduced pressure showing illustrative flow channels; -
FIG. 17 is a schematic, perspective view of an illustrative dressing for use with reduced pressure showing an illustrative liquid-delivery channel; and -
FIG. 18 is schematic, perspective view of a portion of the illustrative dressing ofFIG. 17 showing the peripheral edge of the illustrative liquid-delivery channel. - In the following detailed description of the non-limiting, illustrative embodiments, reference is made to the accompanying drawings that form a part hereof. These embodiments are described in sufficient detail to enable those skilled in the art to practice the invention, and it is understood that other embodiments may be utilized and that logical structural, mechanical, electrical, and chemical changes may be made without departing from the spirit or scope of the invention. To avoid detail not necessary to enable those skilled in the art to practice the embodiments described herein, the description may omit certain information known to those skilled in the art. The following detailed description is, therefore, not to be taken in a limiting sense, and the scope of the illustrative embodiments are defined only by the appended claims.
- Referring now to
FIG. 1 , an illustrative embodiment of asystem 100 for treating anabdominal cavity 102 that includes anabdominal treatment device 104 is presented. Theabdominal treatment device 104 may be, for example, anillustrative dressing 200 for use with reduced pressure as shown inFIG. 2 . Thesystem 100 and theabdominal treatment device 104 are for treating atissue site 106 of a patient. Thetissue site 106 may be the bodily tissue of any human, animal, or other organism, including bone tissue, adipose tissue, muscle tissue, dermal tissue, connective tissue, cartilage, tendons, ligaments, or any other tissue. In this illustrative embodiment, thetissue site 106 includes tissue in a body cavity, and in particular theabdominal cavity 102, and includesabdominal contents 108 or tissue that is proximate theabdominal cavity 102. Treatment of thetissue site 106 may include removal of fluids, e.g., ascites, protection of theabdominal cavity 102, or reduced-pressure therapy. - As shown, the
abdominal treatment device 104 is disposed within theabdominal cavity 102 of the patient to treat thetissue site 106. Theabdominal treatment device 104 is supported by theabdominal contents 108. Theabdominal contents 108 make up a surface on which theabdominal treatment device 104 is placed. Aportion 110 of theabdominal treatment device 104 may be placed in or proximate to a firstparacolic gutter 112, and anotherportion 114 may be placed in or proximate to a secondparacolic gutter 116.FIG. 1 is a schematic drawing and is not to scale and the density of flow paths would typically be higher. - The
abdominal treatment device 104 is formed with a plurality of liquid-impermeable layers 117, e.g., a first liquid-impermeable layer 118 and a second liquid-impermeable layer 120. The plurality of liquid-impermeable layers 117, e.g., layers 118, 120, are formed withfenestrations fenestrations fenestrations abdominal treatment device 104 has afirst side 105 and a second, tissue-facingside 107. Theabdominal treatment device 104 is typically symmetrical such that thesides - A manifold 126, or manifold pad, distributes reduced pressure to the
abdominal treatment device 104. A sealingmember 128 provides a fluid seal over theabdominal cavity 102. One or more skin closure devices may be placed on a patient'sepidermis 130. - A reduced-
pressure connector subsystem 132 may be used to fluidly couple theabdominal treatment device 104 to a reduced-pressure delivery conduit 134. The reduced-pressure connector subsystem 132 may include a reduced-pressure connector 136, or interface, and themanifold 126. Alternatively, the reduced-pressure connector subsystem 132 may be an in situ connector (not shown) on theabdominal treatment device 104 or any other device for supplying reduced pressure to theabdominal treatment device 104. The reduced-pressure delivery conduit 134 is fluidly coupled to a reduced-pressure source 137. In one illustrative embodiment, reduced pressure is delivered to theabdominal treatment device 104 through the manifold 126 which receives reduced pressure through the reduced-pressure connector 136, which is coupled to the reduced-pressure delivery conduit 134. The reduced-pressure source 137 delivers reduced pressure to the reduced-pressure delivery conduit 134. - The reduced pressure may be applied to the
tissue site 106 to help promote removal of ascites, exudates, or other fluids from thetissue site 106. In some instances, reduced pressure may be applied to stimulate the growth of additional tissue. In some instances, only fluid removal may be desired. As used herein, “reduced pressure” generally refers to a pressure less than the ambient pressure at a tissue site that is being subjected to treatment. In most cases, this reduced pressure will be less than the atmospheric pressure at which the patient is located. Alternatively, the reduced pressure may be less than a hydrostatic pressure at the tissue site. - The manifold 126 is shown adjacent to the
abdominal treatment device 104. The manifold 126 may take many forms. The term “manifold” as used herein generally refers to a substance or structure that is provided to assist in applying reduced pressure to, delivering fluids to, or removing fluids from thetissue site 106 directly or via theabdominal treatment device 104. The manifold 126 typically includes a plurality of flow channels or pathways that distribute the fluids provided to and removed from thetissue site 106 around themanifold 126 and through theabdominal treatment device 104. In one illustrative embodiment, the flow channels or pathways are interconnected to improve distribution of fluids provided or removed. The manifold 126 may be a biocompatible material that is capable of being placed in contact with thetissue site 106 and distributing reduced pressure to thetissue site 106 orabdominal treatment device 104. Examples ofmanifold 126 may include, without limitation, devices that have structural elements arranged to form flow channels, cellular foam, such as open-cell foam, porous tissue collections, liquids, gels and foams that include or cure to include flow channels. The manifold 126 may be porous and may be made from foam, gauze, felted mat, or any other material suited to a particular biological application. In one embodiment, the manifold 126 is a porous foam and includes a plurality of interconnected cells or pores that act as flow channels. The porous foam may be a polyurethane, open-cell, reticulated foam, such as a GranuFoam® material manufactured by Kinetic Concepts, Incorporated of San Antonio, Texas. Other embodiments may include “closed cells.” In some situations, the manifold 126 may also be used to distribute fluids, such as medications, antibacterials, growth factors, and various solutions. Other layers may be included in or on the manifold 126, such as absorptive materials, wicking materials, hydrophobic materials, and hydrophilic materials. - The sealing
member 128 is placed over theabdominal cavity 102 and provides a fluid seal. As used herein, “fluid seal,” or “seal,” means a seal adequate to maintain reduced pressure at a desired site given the particular reduced-pressure source or subsystem involved. The sealingmember 128 may be a cover, or drape, that is used to secure the manifold 126 on a portion of theabdominal treatment device 104. The sealingmember 128 may be impermeable or semi-permeable. The sealingmember 128 is capable of maintaining reduced pressure at thetissue site 106 or other desired location after installation of the sealingmember 128 over theabdominal cavity 102 and particularly anabdominal cavity opening 140. The sealingmember 128 may be a flexible over-drape or film formed from a silicone-based compound, acrylic, hydrogel or hydrogel-forming material, polyurethane, polymer film, or any other biocompatible material that includes the impermeability or permeability characteristics as desired for applying reduced pressure to thetissue site 106. - The sealing
member 128 may further include anattachment device 142 to couple the sealingmember 128 to the patient'sepidermis 130. Theattachment device 142 may take many forms. For example, theattachment device 142 may be anadhesive layer 144 that may be positioned along a perimeter of the sealingmember 128 or any portion of the sealingmember 128 to provide, directly or indirectly, a fluid seal with the patient'sepidermis 130. Theadhesive layer 144 may also be pre-applied to the sealingmember 128 and covered with a releasable backing, or member (not shown), that is removed at the time of application. - The reduced-
pressure connector 136 may be, as one example, a port or connector, which permits the passage of fluid from the manifold 126 to the reduced-pressure delivery conduit 134 and vice versa. For example, fluid collected from thetissue site 106 using themanifold 126 and theabdominal treatment device 104 may enter the reduced-pressure delivery conduit 134 via the reduced-pressure connector 136. In another embodiment, thesystem 100 may omit the reduced-pressure connector 136 and the reduced-pressure delivery conduit 134 may be inserted directly into the sealingmember 128 and into themanifold 126. The reduced-pressure delivery conduit 134 may be a medical conduit or tubing or any other means for transportating a reduced pressure and fluid. The reduced-pressure delivery conduit 134 may be a multi-lumen member for readily delivering reduced pressure and removing fluids. In one embodiment, the reduced-pressure delivery conduit 134 is a two-lumen conduit with one lumen for reduced pressure and liquid transport and one lumen for communicating pressure to a pressure sensor. - Reduced pressure is generated and supplied to the reduced-
pressure delivery conduit 134 by the reduced-pressure source 137. A wide range of reduced pressures may be generated or supplied by the reduced-pressure source 137. In one illustrative embodiment, the reduced pressure is in the range of −50 to −300 mm Hg and in another illustrative embodiment, the range may include −100 mm Hg to −200 mm Hg. The pressure may be, for example, −100, −110, −120, −125, −130, −140, −150, −160, −170, −180, −190, or −200 mm Hg. In one illustrative embodiment, the reduced-pressure source 137 includes preset selectors for −100 mm Hg, −125 mm Hg, and −150 mm Hg. The reduced-pressure source 137 may also include a number of alarms, such as a blockage alarm, a leakage alarm, canister full alarm, or a battery-low alarm. The reduced-pressure source 137 may be a portable source, wall source, or other unit for abdominal cavities or other tissue sites. The reduced-pressure source 137 may selectively deliver a constant pressure, varied pressure, intermittent pressure, or continuous pressure. The fluid removed from theabdominal cavity 102 through the reduced-pressure delivery conduit 134 could be as much as 5 L or more per day depending on the circumstances. A fluid reservoir is typically associated with the reduced-pressure source 137 for receiving fluids. - A number of different devices, e.g.,
device 146, may be added to a portion of the reduced-pressure delivery conduit 134. For example, thedevice 146 may be a fluid reservoir, or canister collection member, a pressure-feedback device, a volume detection system, a blood detection system, an infection detection system, a filter, a port with a filter, a flow monitoring system, a temperature monitoring system, etc.Multiple devices 146 may be included. Some of these devices, e.g., the fluid collection member, may be formed integrally to the reduced-pressure source 137. - Referring now primarily to
FIG. 2 , an illustrative, non-limiting embodiment of a dressing 200 that may be used in many situations to distribute reduced pressure and remove fluids is presented. The dressing 200 may be a modular component used in systems or devices. For example, the dressing 200 may be used as theabdominal treatment device 104 ofFIG. 1 or as themanifold member 302 inFIG. 7 . The dressing 200 includes a plurality of liquid-impermeable layers 202, such as a first liquid-impermeable layer 204 and a second liquid-impermeable layer 206, and a plurality ofspacers 208. - The plurality of liquid-
impermeable layers 202 may includefenestrations 203, which may be formed with any shape and size. Thefenestrations 203 allow the egress of reduced pressure and the ingress of fluids. The plurality of liquid-impermeable layers 202 may be formed from numerous materials including the materials used for the sealingmember 128 ofFIG. 1 . - The plurality of
spacers 208 may be disposed (including formed or positioned) at least partially between adjacent members of the plurality of liquid-impermeable layers 202. “Partially” means to some extent or degree. The plurality ofspacers 208 may be formed by portions of the impermeable layers themselves bonded to hold portions of adjacent layers with a relative displacement or may be formed by the layers being folded or in other ways as shown and described herein. Reference to spacers “between” layers means the portions displacing the layers or portions of the layers are at least partially located between the exterior of adjacent layers. For example, a fold has a curved portions between the exteriors of two layers that may be formed from a single layer of material. Thus, the spacer may be said to be between layers even when formed by portions of the layers. The plurality ofspacers 208 provide areas of separation between adjacent members of the plurality of liquid-impermeable layers 202 and thereby help create a plurality offlow paths 210. The figures are not to scale, and it should be understood that theflow paths 210 may be much more dense than shown. For example, theflow paths 210 may be only one millimeter apart, two millimeters apart, three millimeters apart, four millimeters a part, or another dimension. - The plurality of
spacers 208 and plurality of liquid-impermeable layers 202 form the plurality offlow paths 210 for allowing fluid flow under reduced pressure or positive pressure. Adjacent layers of the plurality of liquid-impermeable layers 202 are typically stacked. “Stacked” generally means disposing or forming layers to be adjacent. In some embodiments, foam or other material with flow paths may be included between the liquid-impermeable layers 202. For example, the first liquid-impermeable layer 204 and the second liquid-impermeable layer 206 may share an area A1 and the foam may have an area A2 that is in the range of 0% to 50% of A1 and often includes no foam (i.e., 0% A1). - The plurality of
spacers 208 may be formed in numerous ways including by forming a plurality ofbonds 212 at a plurality ofbond sites 214. The plurality ofbonds 212 may be formed using any known technique, including without limitation welding (e.g., ultrasonic or RF welding), chemical bonding, adhesives, or cements. The plurality ofbond sites 214 may be random or may have a spaced pattern. The plurality ofbonds 212 may have a longitudinal dimension, a lateral dimension, and a vertical dimension (for the orientation shown). The plurality ofbonds 212 may have an aspect ratio (longitudinal dimension/lateral dimension) greater than 3, or greater than 6, or greater still. The plurality ofbonds 212 may also be circular in nature or any other shape. - Referring now primarily to
FIG. 3 , a detail of a portion of the dressing 200 ofFIG. 2 is presented. The dressing 200 is shown without reduced pressure applied.FIG. 4 shows the same detail asFIG. 3 , but with reduced pressure applied. The reduced pressure may draw portions of the adjacent members of the plurality of liquid-impermeable layers 202 closer together, but at least a portion of the plurality offlow paths 210 continue to provide a flow path that may transport reduced pressure and fluids. - Referring now primarily to
FIG. 5 , a schematic plan view showing one possible flow pattern for a portion of the dressing 200 is presented. A reduced-pressure aperture 216 delivers reduced pressure between adjacent layers of the plurality of liquid-impermeable layers 202 and pulls or urges liquid throughfenestrations 203 from a tissue site or cavity and then along the plurality of flow paths 210 (FIG. 3 ) to allowflows streams 218 to reach the reduced-pressure aperture 216. - Referring now primarily to
FIG. 6 , the dressing 200 is shown with the plurality of liquid-impermeable layers 202 including the first liquid-impermeable layer 204, a second liquid-impermeable layer 206, and a third liquid-impermeable layer 207. Thefenestrations 203 may or may not be through the third liquid-impermeable layer 207. In other words, some layers, e.g., third liquid-impermeable layer 207 may not be fenestrated. Additional layers may be added to the plurality of liquid-impermeable layers 202. Thespacers 208 provide at least some separation between adjacent layers of the plurality of liquid-impermeable layers 202 to defineflow paths 210. - Referring now primarily to
FIG. 7 , an illustrative, non-limiting example of a reduced-pressure treatment system 300 is presented that includes amanifold member 302. Themanifold member 302 may be the dressing 200 ofFIG. 2 . The reduced-pressure treatment system 300 provides reduced pressure to atissue site 304, such as anopen wound 306. Thewound 306 may extend throughepidermis 308 and intosubcutaneous tissue 310. - The
manifold member 302 is placed adjacent to thetissue site 304 and then is covered with a sealingmember 312. Anattachment device 314 may be used to help provide a fluid seal over thetissue site 304. Aconnector subsystem 316 may fluidly couple a reduced-pressure delivery conduit 318 and themanifold member 302. The reduced-pressure delivery conduit 318 is also fluidly coupled to a reduced-pressure source 320. Adevice 322 may be fluidly coupled or otherwise associated with the reduced-pressure delivery conduit 318. - The
device 322 is the same or analogous to thedevice 146 ofFIG. 1 . Moreover, many of the components of thesystem 300 ofFIG. 3 are identical or analogous to components of thesystem 100 ofFIG. 1 . As another example, the sealingmember 312 is analogous to the sealingmember 128. Theattachment device 314 is analogous to theattachment device 142 ofFIG. 1 . - In operation, the
manifold member 302 is placed adjacent to thetissue site 304. The sealingmember 312 is applied over thetissue site 304 and a fluid seal is thereby formed. If not already applied, the reduced-pressure connector subsystem 316 is applied to the sealingmember 312. If not already installed, the reduced-pressure delivery conduit 318 is fluidly coupled to the reduced-pressure connector subsystem 316 and to the reduced-pressure source 320. The reduced-pressure source 320 is activated. The reduced pressure is communicated to themanifold member 302 and causes reduced pressure to be delivered to thetissue site 304 through a plurality of flow paths (seeflow paths 210 inFIG. 2 ) and fenestrations (seefenestrations 203 inFIG. 2 ). Fluids collected thereby are removed through reduced-pressure delivery conduit 318. Various micro-stress-inducing elements may be added to the tissue-facing side of themanifold member 302 to promote granulation. The micro-stress-inducing elements may include small buttons, projecting columns, or other devices. - Referring now primarily to
FIG. 8 , a portion of another illustrative, non-limiting embodiment of a dressing 400 is presented. The dressing 400 includes a plurality of liquid-impermeable layers 402, e.g., a first liquid-impermeable layer 404, a second liquid-impermeable layer 406, and a third liquid-impermeable layer 408. The plurality of liquid-impermeable layers 402 is fenestrated withfenestrations 403. The plurality of liquid-impermeable layers 402 are formed with thickness variations orenlarged portions 410 that formspacers 412. Under reduced pressure, thespacers 412 continue to provide a plurality offlow paths 414. The plurality offlow paths 414 function analogously to flowpaths 210 ofFIG. 2 . - Referring now primarily to
FIG. 9 , another portion of an illustrative, non-limiting embodiment of a dressing 500 is presented. The dressing 500 is formed with a plurality of liquid-impermeable layers 502. In this illustrative embodiment, the plurality of liquid-impermeable layers 502 are formed by doubling, or folding, a first liquid-impermeable layer 504 over on itself to form afirst portion 506 and asecond portion 508. The plurality of liquid-impermeable layers 502 is fenestrated (not explicitly shown but analogous to fenestrations 403 inFIG. 8 ). - A
fold 510 has acurved portion 511 with aradius 512. The dressing 500 may have a plurality of folds, such asfold 510. The folds, e.g., 510, serve as spacers. Theradius 512 is relatively larger when thicker materials or more rigid materials are used for the plurality of liquid-impermeable layers 502. Theradius 512 forms a micro-channel 520, which may be one of a plurality offlow paths 518. The first liquid-impermeable layer 504 may be formed with enlarged portions, e.g.,enlarged portions flow paths 518. Theradius 512 may also form or help form one of theflow paths 518. Theflow paths 518 may be formed by a plurality of enlarged portions, e.g.,enlarged portions fold 510 or both. -
FIG. 10 shows the dressing 500 ofFIG. 9 , but a plurality ofbonds 524 has been added at a plurality ofbond sites 526. As an alternative or addition, theflow paths 518 may be formed in dressing 500 by folding the first liquid-impermeable layer 504 on itself, stretching either thefirst portion 506 relative to the second portion 508 (or vice versa) and then adding the plurality ofbonds 524. Once bonded, the portion of the first liquid-impermeable layer 504 in tension may be released. This release will then form a plurality offlow paths 518 between the plurality ofbonds 524. - Referring now primarily to
FIGS. 11-15 , another illustrative, non-limiting embodiment of a dressing 600 is presented. The dressing 600 may be used with numerous reduced-pressure systems, such as in thesystem 100 ofFIG. 1 as theabdominal treatment device 104, or in thesystem 300 ofFIG. 3 as themanifold member 302. Generally, the dressing 600 createsfolds 608 by requiring a two-dimensionalflat layer 602 to form to a three-dimensional body part, orcurved body part 606. Thefolds 608 comprise channels, or flowpaths 612. Thefolds 608 of the dressing 600 facilitate fluid movement. - The dressing 600 is formed with the two-dimensional
flat layer 602, or liquid-impermeable layer 602. The liquid-impermeable layer 602 hasfenestrations 604. Thefenestrations 604 allow the egress of reduced pressure and the ingress of fluids. The liquid-impermeable layer 602 may be formed from any suitable material, such as those mentioned in connection with the liquid-impermeable layers FIGS. 1 and 2 . The liquid-impermeable layer 602 may be single ply, double ply, or multi-ply. As shown inFIG. 12 , the dressing 600 may be formed as a flat oval, but other shapes, e.g., a circle, square, or irregular shape, may be used. While referenced as a two-dimensionalflat layer 602, the two-dimensionalflat layer 602 will have some thickness but will rest flat on a flat surface. - The dressing 600 is for use with the
curved body part 606. Thecurved body 606 may be any part of a patient that is not flat and that typically has a substantial curvature. Referring now primarily toFIG. 12 , as the liquid-impermeable layer 602 is deployed flush against thecurved body part 606, thefolds 608, or plurality of folds, are created. As shown clearly inFIGS. 14 and 15 , the plurality offolds 608 that develop in order for the dressing 600 to rest flush against thecurved body part 606, create the channels or flowpaths 612. Thefolds 608 comprise a plurality ofspacers 610 that provide areas of separation between portions of the liquid-impermeable layer 602 to define the plurality offlow paths 612. Theflow paths 612 may function as micro-channels that facilitate fluid movement. - Referring now primarily to
FIG. 14 , a perspective view of one of the plurality offolds 608 of the dressing 600 is shown. In this illustrative embodiment, the liquid-impermeable layer 602 is a single-ply layer and twofolds 608 are shown. Again, the liquid-impermeable layer 602 may be a multi-layer member. Thefolds 608 comprisespacers 610 and the resultant openings of the folds serve as the micro-channels.FIG. 15 presents a cross section of the portion of the dressing 600 shown inFIG. 14 . - Referring primarily now to
FIG. 16 , another illustrative embodiment of a dressing 700 is presented that may be used with numerous reduced-pressure systems, such assystems FIGS. 1 and 3 . The dressing 700 may be formed with a plurality of liquid-impermeable layers 702 that have fenestrations 704. A plurality of spacers, e.g.,spacers 208 ofFIG. 2 , may be formed between adjacent layers of the plurality of liquid-impermeable layers 702 to form a plurality of flow paths (not shown but analogous to theflow paths 210 ofFIG. 2 ). A plurality of longitudinal members orbonds 706 may be formed on the plurality of liquid-impermeable layers 702 to form a plurality offlow channels 708. For example, a firstlongitudinal bond 710 and a secondlongitudinal bond 712, which is spaced from the firstlongitudinal bond 710, form aflow channel 714. Afirst side 716 may be formed with a reduced-pressure aperture 718 to facilitate fluidly coupling a reduced-pressure source (not shown). Theflow channels 708 direct fluid flowing in flow paths along directed areas of thedressing 700. - Referring now primarily to
FIGS. 17 and 18 , another illustrative, non-limiting embodiment of a dressing 800 is presented. The dressing 800 may be formed with a plurality of liquid-impermeable layers 802. The plurality of liquid-impermeable layers 802 may have fenestrations 804 and may be bonded at bonded sites analogous tobonds 212 atbond sites 214 inFIG. 2 . The dressing 800 may include a liquid-delivery channel 806. - The liquid-
delivery channel 806 may include afirst portion 808. Thefirst portion 808 is part of a first liquid-impermeable layer 810 of the plurality of liquid-impermeable layers 802, but withoutfenestrations 804. The liquid-delivery channel 806 also includes asecond portion 812. Thesecond portion 812 is part of a second liquid-impermeable layer 814 of the plurality of liquid-impermeable layers 802, and again the second liquid-impermeable layer 814 has nofenestrations 804. A channel-formingbond 816 is formed that couples thefirst portion 808 and thesecond portion 812 to form aliquid delivery path 818. Aliquid aperture 820 may be formed on the first liquid-impermeable layer 810 to facilitate fluidly coupling of a liquid-supply source (not shown) to the liquid-delivery channel 806. - In operation, according to one illustrative embodiment, the dressing 800 is deployed as part of a reduced-pressure treatment system proximate the tissue site to be treated. A reduced-pressure source (not shown) is fluidly coupled to a reduced-
pressure aperture 822 to provide reduced pressure to thedressing 800. The reduced pressure pulls fluids into the dressing 800 except for the liquid-delivery channel 806. A fluid-supply source (not shown) is fluidly coupled to theliquid aperture 820. Liquid, e.g., a saline irrigation fluid or medicine, is delivered to theliquid aperture 820. Under the influence of reduced pressure experienced at aperipheral edge 824, liquid delivered to theliquid aperture 820 is urged through theliquid delivery path 818 toward theperipheral edge 824 and exits theliquid delivery channel 806 as suggested byarrows FIG. 17 . The fluid exiting 828 is pulled through asecond portion 830 of the dressing 800 through thefenestrations 804 and toward the reduced-pressure aperture 822. The liquid-delivery channel 806 may be used to irrigate, supply medicines, or other purposes. - Although the present invention and its advantages have been disclosed in the context of certain illustrative, non-limiting embodiments, it should be understood that various changes, substitutions, permutations, and alterations can be made without departing from the scope of the invention as defined by the appended claims. It will be appreciated that any feature that is described in connection to any one embodiment may also be applicable to any other embodiment.
- It will be understood that the benefits and advantages described above may relate to one embodiment or may relate to several embodiments. It will further be understood that reference to ‘an’ item refers to one or more of those items.
- The steps of the methods described herein may be carried out in any suitable order, or simultaneously where appropriate.
- Where appropriate, aspects of any of the examples described above may be combined with aspects of any of the other examples described to form further examples having comparable or different properties and addressing the same or different problems.
- It will be understood that the above description of preferred embodiments is given by way of example only and that various modifications may be made by those skilled in the art. The above specification, examples and data provide a complete description of the structure and use of exemplary embodiments of the invention. Although various embodiments of the invention have been described above with a certain degree of particularity, or with reference to one or more individual embodiments, those skilled in the art could make numerous alterations to the disclosed embodiments without departing from the scope of the claims.
Claims (12)
1. A dressing for distributing reduced pressure to a tissue site, the dressing comprising:
a first layer formed from a liquid impermeable material and having first fenestrations extending through the first layer;
a second layer formed from a liquid impermeable material and having second fenestrations extending through the second layer; and
a plurality of bonds coupling the first layer to the second layer at bond sites defining portions of the first layer and the second layer between adjacent bond sites, wherein at least one set of the first fenestrations and second fenestrations are disposed between adjacent bond sites to define flow paths between the first fenestrations and second fenestrations;
wherein fluid flows through the first layer, the second layer, and the flow paths when reduced pressure is applied to the dressing when positioned at the tissue site.
2. The dressing of claim 1 , wherein the portions of the first layer and the second layer move closer together without closing the flow paths when reduced pressure is applied to the dressing.
3. The dressing of claim 1 , wherein the portions of the first layer and the second layer are sufficiently stiff to prevent the flow paths from closing when reduced pressure is applied to the dressing.
4. The dressing of claim 1 , wherein the bonds stiffen the portions of the first layer and the second layer to prevent the flow paths from closing when reduced pressure is applied to the dressing.
5. The dressing of claim 1 , further comprising a third layer disposed between the first layer and the second layer and coupled to the first layer and the second layer by the plurality of bonds.
6. The dressing of claim 5 , wherein the third layer is formed from a liquid impermeable material.
7. The dressing of claim 5 , wherein the third layer further comprises one or more fenestrations disposed between adjacent bond sites and extending through the third layer.
8. The dressing of claim 1 , wherein at least one of the first and second layers further comprises one or more micro-stress inducing elements formed on a surface of the layer opposite the other of the first and second layers.
9. The dressing of claim 8 , wherein the micro-stress inducing elements comprise at least one of buttons and projecting columns.
10. The dressing of claim 1 , wherein a thickness of either one of the first and second layers is variable.
11. (canceled)
12. (canceled)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16/910,421 US20200315854A1 (en) | 2010-03-11 | 2020-06-24 | Dressings, systems and methods for treating a tissue site |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US31296810P | 2010-03-11 | 2010-03-11 | |
US13/043,315 US8721606B2 (en) | 2010-03-11 | 2011-03-08 | Dressings, systems, and methods for treating a tissue site |
US14/230,487 US9642953B2 (en) | 2010-03-11 | 2014-03-31 | Dressings, systems, and methods for treating a tissue site |
US15/479,013 US10729590B2 (en) | 2010-03-11 | 2017-04-04 | Dressings, systems, and methods for treating a tissue site |
US16/910,421 US20200315854A1 (en) | 2010-03-11 | 2020-06-24 | Dressings, systems and methods for treating a tissue site |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/479,013 Division US10729590B2 (en) | 2010-03-11 | 2017-04-04 | Dressings, systems, and methods for treating a tissue site |
Publications (1)
Publication Number | Publication Date |
---|---|
US20200315854A1 true US20200315854A1 (en) | 2020-10-08 |
Family
ID=44560641
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/043,315 Active 2031-05-30 US8721606B2 (en) | 2010-03-11 | 2011-03-08 | Dressings, systems, and methods for treating a tissue site |
US14/230,487 Active 2032-03-12 US9642953B2 (en) | 2010-03-11 | 2014-03-31 | Dressings, systems, and methods for treating a tissue site |
US15/479,013 Active 2032-12-17 US10729590B2 (en) | 2010-03-11 | 2017-04-04 | Dressings, systems, and methods for treating a tissue site |
US16/910,421 Abandoned US20200315854A1 (en) | 2010-03-11 | 2020-06-24 | Dressings, systems and methods for treating a tissue site |
Family Applications Before (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/043,315 Active 2031-05-30 US8721606B2 (en) | 2010-03-11 | 2011-03-08 | Dressings, systems, and methods for treating a tissue site |
US14/230,487 Active 2032-03-12 US9642953B2 (en) | 2010-03-11 | 2014-03-31 | Dressings, systems, and methods for treating a tissue site |
US15/479,013 Active 2032-12-17 US10729590B2 (en) | 2010-03-11 | 2017-04-04 | Dressings, systems, and methods for treating a tissue site |
Country Status (8)
Country | Link |
---|---|
US (4) | US8721606B2 (en) |
EP (2) | EP2544640B1 (en) |
JP (2) | JP5972799B2 (en) |
CN (1) | CN102781380B (en) |
AU (4) | AU2011224365B2 (en) |
CA (1) | CA2789000C (en) |
TW (1) | TW201200176A (en) |
WO (1) | WO2011112724A1 (en) |
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10968543B2 (en) | 2011-12-01 | 2021-04-06 | Convatec Technologies Inc. | Wound dressing for use in vacuum therapy |
US11116884B2 (en) | 2010-12-08 | 2021-09-14 | Convatec Technologies Inc. | Integrated system for assessing wound exudates |
US11135315B2 (en) | 2010-11-30 | 2021-10-05 | Convatec Technologies Inc. | Composition for detecting biofilms on viable tissues |
US11241339B2 (en) | 2011-11-29 | 2022-02-08 | Convatec Inc. | Perforated binder for laminated wound dressing |
US11241525B2 (en) | 2010-12-08 | 2022-02-08 | Convatec Technologies Inc. | Wound exudate monitor accessory |
US11266774B2 (en) | 2016-07-08 | 2022-03-08 | Convatec Technologies Inc. | Fluid collection apparatus |
US11286601B2 (en) | 2012-12-20 | 2022-03-29 | Convatec Technologies, Inc. | Processing of chemically modified cellulosic fibres |
US11331221B2 (en) | 2019-12-27 | 2022-05-17 | Convatec Limited | Negative pressure wound dressing |
US11452808B2 (en) | 2016-07-08 | 2022-09-27 | Convatec Technologies Inc. | Fluid flow sensing |
US11458044B2 (en) | 2008-09-29 | 2022-10-04 | Convatec Technologies Inc. | Wound dressing |
US11583430B2 (en) | 2011-09-02 | 2023-02-21 | Convatec Ltd. | Skin contact material |
US11596554B2 (en) | 2016-07-08 | 2023-03-07 | Convatec Technologies Inc. | Flexible negative pressure system |
US11628093B2 (en) | 2008-05-08 | 2023-04-18 | Convatec Technologies, Inc. | Wound dressing |
US11723808B2 (en) | 2016-03-30 | 2023-08-15 | Convatec Technologies Inc. | Detecting microbial infections in wounds |
US11740241B2 (en) | 2016-03-30 | 2023-08-29 | Synovo Gmbh | Construct including an anchor, an enzyme recognition site and an indicator region for detecting microbial infection in wounds |
US11771819B2 (en) | 2019-12-27 | 2023-10-03 | Convatec Limited | Low profile filter devices suitable for use in negative pressure wound therapy systems |
Families Citing this family (157)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0224986D0 (en) | 2002-10-28 | 2002-12-04 | Smith & Nephew | Apparatus |
GB0325129D0 (en) | 2003-10-28 | 2003-12-03 | Smith & Nephew | Apparatus in situ |
US10058642B2 (en) | 2004-04-05 | 2018-08-28 | Bluesky Medical Group Incorporated | Reduced pressure treatment system |
US7909805B2 (en) | 2004-04-05 | 2011-03-22 | Bluesky Medical Group Incorporated | Flexible reduced pressure treatment appliance |
EP1922045B1 (en) | 2005-09-07 | 2012-11-07 | Tyco Healthcare Group LP | Self contained wound dressing with micropump |
US7779625B2 (en) | 2006-05-11 | 2010-08-24 | Kalypto Medical, Inc. | Device and method for wound therapy |
US9820888B2 (en) | 2006-09-26 | 2017-11-21 | Smith & Nephew, Inc. | Wound dressing |
AU2008327660B2 (en) | 2007-11-21 | 2014-02-13 | Smith & Nephew Plc | Wound dressing |
GB0722820D0 (en) | 2007-11-21 | 2008-01-02 | Smith & Nephew | Vacuum assisted wound dressing |
AU2008327661B2 (en) | 2007-11-21 | 2014-02-20 | Smith & Nephew Plc | Wound dressing |
US11253399B2 (en) | 2007-12-06 | 2022-02-22 | Smith & Nephew Plc | Wound filling apparatuses and methods |
US20130096518A1 (en) | 2007-12-06 | 2013-04-18 | Smith & Nephew Plc | Wound filling apparatuses and methods |
GB0723855D0 (en) | 2007-12-06 | 2008-01-16 | Smith & Nephew | Apparatus and method for wound volume measurement |
GB2455962A (en) | 2007-12-24 | 2009-07-01 | Ethicon Inc | Reinforced adhesive backing sheet, for plaster |
WO2009111655A2 (en) | 2008-03-05 | 2009-09-11 | Kcl Licensing Inc. | Dressing and method for applying reduced pressure to and collecting and storing fluid from a tissue site |
GB0804654D0 (en) | 2008-03-13 | 2008-04-16 | Smith & Nephew | Vacuum closure device |
US9199012B2 (en) | 2008-03-13 | 2015-12-01 | Smith & Nephew, Inc. | Shear resistant wound dressing for use in vacuum wound therapy |
US8814842B2 (en) | 2010-03-16 | 2014-08-26 | Kci Licensing, Inc. | Delivery-and-fluid-storage bridges for use with reduced-pressure systems |
US9061095B2 (en) | 2010-04-27 | 2015-06-23 | Smith & Nephew Plc | Wound dressing and method of use |
GB201015656D0 (en) | 2010-09-20 | 2010-10-27 | Smith & Nephew | Pressure control apparatus |
GB201020005D0 (en) | 2010-11-25 | 2011-01-12 | Smith & Nephew | Composition 1-1 |
JP6078472B2 (en) | 2010-11-25 | 2017-02-08 | スミス アンド ネフュー ピーエルシーSmith & Nephew Public Limited Company | Compositions I-II and products and their use |
US9352075B2 (en) | 2010-12-07 | 2016-05-31 | Kci Licensing, Inc. | Wound healing apparatus for promoting granulation and epithelialization at a tissue site |
GB2488749A (en) | 2011-01-31 | 2012-09-12 | Systagenix Wound Man Ip Co Bv | Laminated silicone coated wound dressing |
RU2756986C2 (en) | 2011-02-04 | 2021-10-08 | Юниверсити Оф Массачусетс | Wound closure device with the creation of negative pressure |
US9421132B2 (en) | 2011-02-04 | 2016-08-23 | University Of Massachusetts | Negative pressure wound closure device |
CA2833232C (en) | 2011-04-15 | 2018-05-22 | University Of Massachusetts | Surgical cavity drainage and closure system |
GB201106491D0 (en) | 2011-04-15 | 2011-06-01 | Systagenix Wound Man Ip Co Bv | Patterened silicone coating |
GB201108229D0 (en) | 2011-05-17 | 2011-06-29 | Smith & Nephew | Tissue healing |
AU2012333210B2 (en) * | 2011-06-24 | 2017-01-19 | Solventum Intellectual Properties Company | Reduced-pressure dressings employing tissue-fixation elements |
US9877872B2 (en) * | 2011-07-14 | 2018-01-30 | Smith & Nephew Plc | Wound dressing and method of treatment |
US9084845B2 (en) | 2011-11-02 | 2015-07-21 | Smith & Nephew Plc | Reduced pressure therapy apparatuses and methods of using same |
US20150159066A1 (en) | 2011-11-25 | 2015-06-11 | Smith & Nephew Plc | Composition, apparatus, kit and method and uses thereof |
EP2787943B2 (en) | 2011-12-07 | 2018-02-28 | KCI Licensing, Inc. | Synthetic granulating gauze for use with reduced-pressure treatment systems |
EP2802304B1 (en) | 2011-12-16 | 2015-12-09 | KCI Licensing, Inc. | Releasable medical drapes |
US10940047B2 (en) | 2011-12-16 | 2021-03-09 | Kci Licensing, Inc. | Sealing systems and methods employing a hybrid switchable drape |
JP6250571B2 (en) | 2012-03-12 | 2017-12-20 | スミス アンド ネフュー ピーエルシーSmith & Nephew Public Limited Company | Pressure reducing apparatus and method |
EP2827917B1 (en) | 2012-03-20 | 2019-10-16 | Smith & Nephew plc | Controlling operation of a reduced pressure therapy system based on dynamic duty cycle threshold determination |
USD733896S1 (en) | 2012-05-04 | 2015-07-07 | Genadyne Biotechnologies, Inc. | Abdominal dressing |
US9427505B2 (en) | 2012-05-15 | 2016-08-30 | Smith & Nephew Plc | Negative pressure wound therapy apparatus |
JP2015528025A (en) | 2012-05-18 | 2015-09-24 | ビーエーエスエフ ソシエタス・ヨーロピアBasf Se | Dust control aggregate |
EP2849880A1 (en) | 2012-05-18 | 2015-03-25 | Basf Se | Encapsulated particle |
US10070994B2 (en) | 2012-05-22 | 2018-09-11 | Smith & Nephew Plc | Apparatuses and methods for wound therapy |
EP2852419B1 (en) | 2012-05-22 | 2019-11-20 | Smith & Nephew plc | Wound closure device |
EP3354293B1 (en) | 2012-05-23 | 2019-12-11 | Smith & Nephew plc | Apparatuses for negative pressure wound therapy |
EP3470029A1 (en) | 2012-05-24 | 2019-04-17 | Smith & Nephew, Inc. | Devices for treating and closing wounds with negative pressure |
AU2013290346B2 (en) | 2012-07-16 | 2018-06-07 | Smith & Nephew, Inc. | Negative pressure wound closure device |
RU2015106111A (en) | 2012-08-01 | 2016-09-27 | СМИТ ЭНД НЕФЬЮ ПиЭлСи | Wound dressing and method of treatment |
US10667955B2 (en) | 2012-08-01 | 2020-06-02 | Smith & Nephew Plc | Wound dressing and method of treatment |
KR20150085837A (en) | 2012-11-16 | 2015-07-24 | 케이씨아이 라이센싱 인코포레이티드 | Medical drafe with pattern adhesive layers and method of manufacturing same |
US9944568B2 (en) | 2012-11-16 | 2018-04-17 | Basf Se | Encapsulated fertilizer particle containing pesticide |
US9681936B2 (en) * | 2012-11-30 | 2017-06-20 | Covidien Lp | Multi-layer porous film material |
GB201222770D0 (en) | 2012-12-18 | 2013-01-30 | Systagenix Wound Man Ip Co Bv | Wound dressing with adhesive margin |
EP2752176B1 (en) * | 2013-01-08 | 2024-03-20 | BSN medical GmbH | Antimicrobially active wound dressing for fixing catheters |
GB201317746D0 (en) | 2013-10-08 | 2013-11-20 | Smith & Nephew | PH indicator |
AU2014216501B8 (en) * | 2013-02-12 | 2018-09-20 | Electrochemical Oxygen Concepts, Inc. | Dressing for wound treatment |
MX369065B (en) | 2013-03-13 | 2019-10-28 | Smith & Nephew Inc | Negative pressure wound closure device and systems and methods of use in treating wounds with negative pressure. |
EP3434236B1 (en) | 2013-03-14 | 2021-12-29 | 3M Innovative Properties Company | Absorbent dressing with hybrid drape |
AU2014229749B2 (en) | 2013-03-14 | 2018-09-20 | Smith & Nephew Plc | Compressible wound fillers and systems and methods of use in treating wounds with negative pressure |
US20160120706A1 (en) | 2013-03-15 | 2016-05-05 | Smith & Nephew Plc | Wound dressing sealant and use thereof |
AU2014229777B2 (en) | 2013-03-15 | 2018-03-08 | Smith & Nephew Plc | Wound dressing and method of treatment |
US10695226B2 (en) | 2013-03-15 | 2020-06-30 | Smith & Nephew Plc | Wound dressing and method of treatment |
EP2815731A1 (en) * | 2013-06-18 | 2014-12-24 | Mölnlycke Health Care AB | Fluid transport dressing |
CA2918157A1 (en) | 2013-07-16 | 2015-01-22 | Smith & Nephew Plc | Apparatus for wound therapy |
EP3038667B1 (en) | 2013-08-26 | 2019-10-09 | KCI Licensing, Inc. | Dressing interface with moisture controlling feature and sealing function |
JP6723917B2 (en) | 2013-10-21 | 2020-07-15 | スミス アンド ネフュー インコーポレイテッド | Negative pressure wound closure device |
WO2015065742A1 (en) | 2013-10-28 | 2015-05-07 | Kci Licensing, Inc. | Hybrid sealing tape |
WO2015065616A1 (en) | 2013-10-30 | 2015-05-07 | Kci Licensing, Inc. | Dressing with sealing and retention intereface |
EP3062751B1 (en) | 2013-10-30 | 2017-08-09 | KCI Licensing, Inc. | Condensate absorbing and dissipating system |
US9925092B2 (en) | 2013-10-30 | 2018-03-27 | Kci Licensing, Inc. | Absorbent conduit and system |
EP3062752B1 (en) | 2013-10-30 | 2017-03-01 | KCI Licensing, Inc. | Dressing with differentially sized perforations |
RU2016133734A (en) | 2014-01-21 | 2018-03-02 | СМИТ ЭНД НЕФЬЮ ПиЭлСи | DEVICE FOR TREATMENT OF THE RAS |
AU2015208299B2 (en) | 2014-01-21 | 2019-11-21 | Smith & Nephew Plc | Collapsible dressing for negative pressure wound treatment |
WO2015130471A1 (en) | 2014-02-28 | 2015-09-03 | Kci Licensing, Inc. | Hybrid drape having a gel-coated perforated mesh |
US11026844B2 (en) | 2014-03-03 | 2021-06-08 | Kci Licensing, Inc. | Low profile flexible pressure transmission conduit |
US10226566B2 (en) | 2014-04-23 | 2019-03-12 | Genadyne Biotechnologies, Inc. | System and process for removing bodily fluids from a body opening |
WO2015168681A1 (en) | 2014-05-02 | 2015-11-05 | Kci Licensing, Inc. | Fluid storage devices, systems, and methods |
CN111839658A (en) * | 2014-05-09 | 2020-10-30 | 凯希特许有限公司 | Destructive dressing for use with negative pressure and fluid instillation |
JP6640748B2 (en) | 2014-06-05 | 2020-02-05 | ケーシーアイ ライセンシング インコーポレイテッド | Dressing with fluid acquisition and dispensing features |
WO2015193257A1 (en) | 2014-06-18 | 2015-12-23 | Smith & Nephew Plc | Wound dressing |
US9770369B2 (en) | 2014-08-08 | 2017-09-26 | Neogenix, Llc | Wound care devices, apparatus, and treatment methods |
CN106794288A (en) * | 2014-10-14 | 2017-05-31 | 凯希特许有限公司 | For the system that the conjunction rule monitored to negative pressure wound therapy use |
WO2016100098A1 (en) | 2014-12-17 | 2016-06-23 | Kci Licensing, Inc. | Dressing with offloading capability |
WO2016103032A1 (en) | 2014-12-22 | 2016-06-30 | Smith & Nephew Plc | Negative pressure wound therapy apparatus and methods |
EP3900685A1 (en) * | 2015-01-14 | 2021-10-27 | 3M Innovative Properties Co. | Closed abdominal manifold dressing |
DK3288508T3 (en) | 2015-04-27 | 2020-03-09 | Smith & Nephew | REDUCED PRESSURE DEVICES |
WO2016176513A1 (en) * | 2015-04-29 | 2016-11-03 | Smith & Nephew Inc. | Negative pressure wound closure device |
EP3294245B1 (en) | 2015-05-08 | 2019-09-04 | KCI Licensing, Inc. | Low acuity dressing with integral pump |
US10076594B2 (en) | 2015-05-18 | 2018-09-18 | Smith & Nephew Plc | Fluidic connector for negative pressure wound therapy |
WO2017040045A1 (en) * | 2015-09-01 | 2017-03-09 | Kci Licensing, Inc. | Dressing with increased apposition force |
EP3349807B1 (en) | 2015-09-17 | 2021-02-24 | 3M Innovative Properties Company | Hybrid silicone and acrylic adhesive cover for use with wound treatment |
US10814049B2 (en) | 2015-12-15 | 2020-10-27 | University Of Massachusetts | Negative pressure wound closure devices and methods |
US10575991B2 (en) | 2015-12-15 | 2020-03-03 | University Of Massachusetts | Negative pressure wound closure devices and methods |
WO2017114745A1 (en) | 2015-12-30 | 2017-07-06 | Smith & Nephew Plc | Negative pressure wound therapy apparatus |
WO2017115146A1 (en) | 2015-12-30 | 2017-07-06 | Smith & Nephew Plc | Absorbent negative pressure wound therapy dressing |
USD796735S1 (en) | 2016-02-29 | 2017-09-05 | Smith & Nephew Plc | Mount apparatus for portable negative pressure apparatus |
JP1586115S (en) | 2016-02-29 | 2017-09-19 | ||
CN109069708B (en) | 2016-03-04 | 2022-04-12 | 史密夫及内修公开有限公司 | Negative pressure wound therapy device for wounds after breast surgery |
CN114053031A (en) | 2016-03-07 | 2022-02-18 | 史密夫及内修公开有限公司 | Wound therapy apparatus and method utilizing a negative pressure source integrated into a wound dressing |
CA3022184A1 (en) | 2016-04-26 | 2017-11-02 | Smith & Nephew Plc | Wound dressings and methods of use with integrated negative pressure source having a fluid ingress inhibition component |
EP3452129B1 (en) | 2016-05-03 | 2022-03-23 | Smith & Nephew plc | Negative pressure wound therapy device activation and control |
CN109069711A (en) | 2016-05-03 | 2018-12-21 | 史密夫及内修公开有限公司 | System and method for driving negative pressure source in negative pressure treatment system |
CA3038206A1 (en) | 2016-05-03 | 2017-11-09 | Smith & Nephew Plc | Optimizing power transfer to negative pressure sources in negative pressure therapy systems |
CA3034789A1 (en) | 2016-08-25 | 2018-03-01 | Smith & Nephew Plc | Absorbent negative pressure wound therapy dressing |
EP3506865B1 (en) | 2016-08-30 | 2021-10-06 | Smith & Nephew plc | Systems for applying reduced pressure therapy |
WO2018044949A1 (en) * | 2016-08-30 | 2018-03-08 | Smith & Nephew, Inc. | Wound closure devices |
EP3518847B1 (en) | 2016-09-27 | 2023-03-01 | Smith & Nephew plc | Wound closure devices with dissolvable portions |
AU2017336310B2 (en) | 2016-09-30 | 2022-12-08 | Smith & Nephew Plc | Negative pressure wound treatment apparatuses and methods with integrated electronics |
GB2555584B (en) | 2016-10-28 | 2020-05-27 | Smith & Nephew | Multi-layered wound dressing and method of manufacture |
WO2018085457A1 (en) | 2016-11-02 | 2018-05-11 | Smith & Nephew Inc. | Wound closure devices |
WO2018108784A1 (en) | 2016-12-12 | 2018-06-21 | Smith & Nephew Plc | Wound dressing |
WO2018125845A1 (en) | 2016-12-27 | 2018-07-05 | Vasonics, Llc | Catheter housing |
EP3573677A2 (en) * | 2017-01-27 | 2019-12-04 | KCI Licensing, Inc. | Multi-layer abdominal closure dressing with instillation capabilities |
WO2018162613A1 (en) | 2017-03-08 | 2018-09-13 | Smith & Nephew Plc | Negative pressure wound therapy device control in presence of fault condition |
CN110612131B (en) | 2017-05-09 | 2023-05-16 | 史密夫及内修公开有限公司 | Redundant control for negative pressure wound therapy system |
EP3634335B1 (en) | 2017-06-07 | 2023-05-24 | 3M Innovative Properties Company | Composite dressings for improved granulation and reduced maceration with negative-pressure treatment |
EP3634337B1 (en) | 2017-06-07 | 2023-05-24 | 3M Innovative Properties Company | Methods for manufacturing and assembling dual material tissue interface for negative-pressure therapy |
EP3634330A1 (en) | 2017-06-07 | 2020-04-15 | KCI Licensing, Inc. | Composite dressings for improved granulation reduced maceration with negative-pressure treatment |
EP3634336B1 (en) * | 2017-06-07 | 2022-07-27 | 3M Innovative Properties Company | Composite dressings for improved granulation and reduced maceration with negative-pressure treatment |
CA3061327A1 (en) | 2017-06-07 | 2018-12-13 | Kci Licensing, Inc. | Peel and place dressing for negative-pressure therapy |
CA3065381A1 (en) | 2017-06-07 | 2018-12-13 | Kci Licensing, Inc. | Tissue contact interface |
WO2018226669A1 (en) * | 2017-06-07 | 2018-12-13 | Kci Licensing, Inc. | Multi-layer wound filler for extended wear time |
CA3065379A1 (en) * | 2017-06-07 | 2018-12-13 | Kci Licensing, Inc. | Systems, apparatuses, and methods for negative-pressure treatment with reduced tissue in-growth |
CN110944607A (en) | 2017-06-07 | 2020-03-31 | 凯希特许有限公司 | Method of manufacturing and assembling a bi-material tissue interface for negative pressure therapy |
EP4233814A3 (en) * | 2017-06-12 | 2023-09-13 | 3M Innovative Properties Company | Fabric wound filler |
US11324876B2 (en) * | 2017-06-13 | 2022-05-10 | Smith & Nephew Plc | Collapsible structure and method of use |
US11872110B2 (en) | 2017-06-13 | 2024-01-16 | Smith & Nephew Plc | Wound closure device and method of use |
EP3638170B1 (en) | 2017-06-14 | 2024-03-13 | Smith & Nephew PLC | Collapsible structure for wound closure and method of use |
WO2018231878A1 (en) | 2017-06-14 | 2018-12-20 | Smith & Nephew, Inc. | Fluid removal management and control of wound closure in wound therapy |
US11724020B2 (en) | 2017-06-14 | 2023-08-15 | Smith & Nephew Plc | Collapsible sheet for wound closure and method of use |
US11395873B2 (en) | 2017-06-14 | 2022-07-26 | Smith & Nephew, Inc. | Control of wound closure and fluid removal management in wound therapy |
WO2018229008A1 (en) | 2017-06-14 | 2018-12-20 | Smith & Nephew Plc | Negative pressure wound therapy apparatus |
WO2019020544A1 (en) | 2017-07-27 | 2019-01-31 | Smith & Nephew Plc | Customizable wound closure device and method of use |
EP3661570B1 (en) * | 2017-08-02 | 2022-12-28 | 3M Innovative Properties Company | Multi-layer compartment dressing |
US11590030B2 (en) | 2017-08-07 | 2023-02-28 | Smith & Nephew Plc | Wound closure device with protective layer and method of use |
US11375923B2 (en) | 2017-08-29 | 2022-07-05 | Smith & Nephew Plc | Systems and methods for monitoring wound closure |
AU2018331954A1 (en) | 2017-09-13 | 2020-03-19 | Smith & Nephew Plc | Negative pressure wound treatment apparatuses and methods with integrated electronics |
GB201718070D0 (en) | 2017-11-01 | 2017-12-13 | Smith & Nephew | Negative pressure wound treatment apparatuses and methods with integrated electronics |
GB201718054D0 (en) | 2017-11-01 | 2017-12-13 | Smith & Nephew | Sterilization of integrated negative pressure wound treatment apparatuses and sterilization methods |
EP3703632B1 (en) | 2017-11-01 | 2024-04-03 | Smith & Nephew plc | Negative pressure wound treatment apparatuses and methods with integrated electronics |
GB201718072D0 (en) | 2017-11-01 | 2017-12-13 | Smith & Nephew | Negative pressure wound treatment apparatuses and methods with integrated electronics |
JP2021517021A (en) | 2018-03-12 | 2021-07-15 | スリーエム イノベイティブ プロパティズ カンパニー | Dressing with different surface features used in the compartment |
CN108498856A (en) * | 2018-05-23 | 2018-09-07 | 浙江大学 | A kind of customized wound dressing and preparation method thereof |
JP2021529590A (en) | 2018-06-25 | 2021-11-04 | ヴァソニクス・エルエルシー | Catheter fixation, stabilization, and antibacterial devices |
GB201811449D0 (en) | 2018-07-12 | 2018-08-29 | Smith & Nephew | Apparatuses and methods for negative pressure wound therapy |
US20220111138A1 (en) * | 2018-09-12 | 2022-04-14 | Kci Licensing, Inc. | Systems, apparatuses, and methods for negative-pressure treatment with reduced tissue in-growth |
USD898925S1 (en) | 2018-09-13 | 2020-10-13 | Smith & Nephew Plc | Medical dressing |
EP3866871A1 (en) * | 2018-10-15 | 2021-08-25 | KCI Licensing, Inc. | Micro balloon-on-tube wound filler |
EP3893825A1 (en) | 2018-12-13 | 2021-10-20 | University of Massachusetts | Negative pressure wound closure devices and methods |
WO2020159675A1 (en) * | 2019-01-28 | 2020-08-06 | Kci Licensing, Inc. | Tearable dressing structure |
USD907216S1 (en) * | 2019-02-07 | 2021-01-05 | Kci Licensing, Inc. | Therapy device |
JP2022531851A (en) * | 2019-05-08 | 2022-07-12 | ケーシーアイ ライセンシング インコーポレイテッド | Manifold with biologically active material for negative pressure therapy |
WO2020256837A1 (en) * | 2019-06-17 | 2020-12-24 | Kci Licensing, Inc. | Abdominal negative-pressure therapy dressing with closed-loop force management control |
WO2021019460A1 (en) * | 2019-07-30 | 2021-02-04 | Kci Licensing, Inc. | Negative-pressure dressing for foot treatment |
WO2021024110A1 (en) * | 2019-08-06 | 2021-02-11 | Kci Licensing, Inc. | Hand dressing for use with negative pressure wound therapy, negative pressure wound therapy system comprising the same, method for controlling a pump coupled to said dressing |
USD945629S1 (en) * | 2020-09-08 | 2022-03-08 | Kci Manufacturing Unlimited Company | Therapy device |
WO2022123361A1 (en) * | 2020-12-07 | 2022-06-16 | Kci Manufacturing Unlimited Company | Extendable depth dressings with transparent capabililty |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040030304A1 (en) * | 2000-05-09 | 2004-02-12 | Kenneth Hunt | Abdominal wound dressing |
US20100106115A1 (en) * | 2008-10-29 | 2010-04-29 | Ian Hardman | Open-cavity, reduced-pressure treatment devices and systems |
Family Cites Families (164)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1355846A (en) | 1920-02-06 | 1920-10-19 | David A Rannells | Medical appliance |
US2547758A (en) | 1949-01-05 | 1951-04-03 | Wilmer B Keeling | Instrument for treating the male urethra |
US2632443A (en) | 1949-04-18 | 1953-03-24 | Eleanor P Lesher | Surgical dressing |
GB692578A (en) | 1949-09-13 | 1953-06-10 | Minnesota Mining & Mfg | Improvements in or relating to drape sheets for surgical use |
US2682873A (en) | 1952-07-30 | 1954-07-06 | Johnson & Johnson | General purpose protective dressing |
NL189176B (en) | 1956-07-13 | 1900-01-01 | Hisamitsu Pharmaceutical Co | PLASTER BASED ON A SYNTHETIC RUBBER. |
US2969057A (en) | 1957-11-04 | 1961-01-24 | Brady Co W H | Nematodic swab |
US2896618A (en) * | 1958-01-21 | 1959-07-28 | Johnson & Johnson | Corrugated dressing |
US3066672A (en) | 1960-09-27 | 1962-12-04 | Jr William H Crosby | Method and apparatus for serial sampling of intestinal juice |
US3367332A (en) | 1965-08-27 | 1968-02-06 | Gen Electric | Product and process for establishing a sterile area of skin |
US3520300A (en) | 1967-03-15 | 1970-07-14 | Amp Inc | Surgical sponge and suction device |
US3568675A (en) | 1968-08-30 | 1971-03-09 | Clyde B Harvey | Fistula and penetrating wound dressing |
US3682180A (en) | 1970-06-08 | 1972-08-08 | Coilform Co Inc | Drain clip for surgical drain |
BE789293Q (en) | 1970-12-07 | 1973-01-15 | Parke Davis & Co | MEDICO-SURGICAL DRESSING FOR BURNS AND SIMILAR LESIONS |
US3826254A (en) | 1973-02-26 | 1974-07-30 | Verco Ind | Needle or catheter retaining appliance |
DE2527706A1 (en) | 1975-06-21 | 1976-12-30 | Hanfried Dr Med Weigand | DEVICE FOR THE INTRODUCTION OF CONTRAST AGENTS INTO AN ARTIFICIAL INTESTINAL OUTLET |
DE2640413C3 (en) | 1976-09-08 | 1980-03-27 | Richard Wolf Gmbh, 7134 Knittlingen | Catheter monitor |
NL7710909A (en) | 1976-10-08 | 1978-04-11 | Smith & Nephew | COMPOSITE STRAPS. |
GB1562244A (en) | 1976-11-11 | 1980-03-05 | Lock P M | Wound dressing materials |
US4080970A (en) | 1976-11-17 | 1978-03-28 | Miller Thomas J | Post-operative combination dressing and internal drain tube with external shield and tube connector |
US4139004A (en) | 1977-02-17 | 1979-02-13 | Gonzalez Jr Harry | Bandage apparatus for treating burns |
US4184510A (en) | 1977-03-15 | 1980-01-22 | Fibra-Sonics, Inc. | Valued device for controlling vacuum in surgery |
US4165748A (en) | 1977-11-07 | 1979-08-28 | Johnson Melissa C | Catheter tube holder |
US4245637A (en) | 1978-07-10 | 1981-01-20 | Nichols Robert L | Shutoff valve sleeve |
SE414994B (en) | 1978-11-28 | 1980-09-01 | Landstingens Inkopscentral | VENKATETERFORBAND |
GB2047543B (en) | 1978-12-06 | 1983-04-20 | Svedman Paul | Device for treating tissues for example skin |
US4266545A (en) | 1979-04-06 | 1981-05-12 | Moss James P | Portable suction device for collecting fluids from a closed wound |
US4284079A (en) | 1979-06-28 | 1981-08-18 | Adair Edwin Lloyd | Method for applying a male incontinence device |
US4261363A (en) | 1979-11-09 | 1981-04-14 | C. R. Bard, Inc. | Retention clips for body fluid drains |
US4569348A (en) | 1980-02-22 | 1986-02-11 | Velcro Usa Inc. | Catheter tube holder strap |
ATE14835T1 (en) | 1980-03-11 | 1985-08-15 | Schmid Eduard | SKIN GRAFT PRESSURE BANDAGE. |
US4297995A (en) | 1980-06-03 | 1981-11-03 | Key Pharmaceuticals, Inc. | Bandage containing attachment post |
US4333468A (en) | 1980-08-18 | 1982-06-08 | Geist Robert W | Mesentery tube holder apparatus |
US4465485A (en) | 1981-03-06 | 1984-08-14 | Becton, Dickinson And Company | Suction canister with unitary shut-off valve and filter features |
US4392853A (en) | 1981-03-16 | 1983-07-12 | Rudolph Muto | Sterile assembly for protecting and fastening an indwelling device |
US4373519A (en) | 1981-06-26 | 1983-02-15 | Minnesota Mining And Manufacturing Company | Composite wound dressing |
US4392858A (en) | 1981-07-16 | 1983-07-12 | Sherwood Medical Company | Wound drainage device |
US4419097A (en) | 1981-07-31 | 1983-12-06 | Rexar Industries, Inc. | Attachment for catheter tube |
AU550575B2 (en) | 1981-08-07 | 1986-03-27 | Richard Christian Wright | Wound drainage device |
SE429197B (en) | 1981-10-14 | 1983-08-22 | Frese Nielsen | SAR TREATMENT DEVICE |
DE3146266A1 (en) | 1981-11-21 | 1983-06-01 | B. Braun Melsungen Ag, 3508 Melsungen | COMBINED DEVICE FOR A MEDICAL SUCTION DRAINAGE |
US4551139A (en) | 1982-02-08 | 1985-11-05 | Marion Laboratories, Inc. | Method and apparatus for burn wound treatment |
US4475909A (en) | 1982-05-06 | 1984-10-09 | Eisenberg Melvin I | Male urinary device and method for applying the device |
EP0100148B1 (en) | 1982-07-06 | 1986-01-08 | Dow Corning Limited | Medical-surgical dressing and a process for the production thereof |
NZ206837A (en) | 1983-01-27 | 1986-08-08 | Johnson & Johnson Prod Inc | Thin film adhesive dressing:backing material in three sections |
US4548202A (en) | 1983-06-20 | 1985-10-22 | Ethicon, Inc. | Mesh tissue fasteners |
US4540412A (en) | 1983-07-14 | 1985-09-10 | The Kendall Company | Device for moist heat therapy |
US4543100A (en) | 1983-11-01 | 1985-09-24 | Brodsky Stuart A | Catheter and drain tube retainer |
US4525374A (en) | 1984-02-27 | 1985-06-25 | Manresa, Inc. | Treating hydrophobic filters to render them hydrophilic |
GB2157958A (en) | 1984-05-03 | 1985-11-06 | Ernest Edward Austen Bedding | Ball game net support |
US4897081A (en) | 1984-05-25 | 1990-01-30 | Thermedics Inc. | Percutaneous access device |
US5215522A (en) | 1984-07-23 | 1993-06-01 | Ballard Medical Products | Single use medical aspirating device and method |
GB8419745D0 (en) | 1984-08-02 | 1984-09-05 | Smith & Nephew Ass | Wound dressing |
US4872450A (en) | 1984-08-17 | 1989-10-10 | Austad Eric D | Wound dressing and method of forming same |
US4655754A (en) | 1984-11-09 | 1987-04-07 | Stryker Corporation | Vacuum wound drainage system and lipids baffle therefor |
US4826494A (en) | 1984-11-09 | 1989-05-02 | Stryker Corporation | Vacuum wound drainage system |
US4605399A (en) | 1984-12-04 | 1986-08-12 | Complex, Inc. | Transdermal infusion device |
US5037397A (en) | 1985-05-03 | 1991-08-06 | Medical Distributors, Inc. | Universal clamp |
US4640688A (en) | 1985-08-23 | 1987-02-03 | Mentor Corporation | Urine collection catheter |
US4710165A (en) | 1985-09-16 | 1987-12-01 | Mcneil Charles B | Wearable, variable rate suction/collection device |
US4758220A (en) | 1985-09-26 | 1988-07-19 | Alcon Laboratories, Inc. | Surgical cassette proximity sensing and latching apparatus |
US4733659A (en) | 1986-01-17 | 1988-03-29 | Seton Company | Foam bandage |
EP0256060A1 (en) | 1986-01-31 | 1988-02-24 | OSMOND, Roger L. W. | Suction system for wound and gastro-intestinal drainage |
US4838883A (en) | 1986-03-07 | 1989-06-13 | Nissho Corporation | Urine-collecting device |
JPS62281965A (en) | 1986-05-29 | 1987-12-07 | テルモ株式会社 | Catheter and catheter fixing member |
GB8621884D0 (en) | 1986-09-11 | 1986-10-15 | Bard Ltd | Catheter applicator |
GB2195255B (en) | 1986-09-30 | 1991-05-01 | Vacutec Uk Limited | Apparatus for vacuum treatment of an epidermal surface |
US4743232A (en) | 1986-10-06 | 1988-05-10 | The Clinipad Corporation | Package assembly for plastic film bandage |
DE3634569A1 (en) | 1986-10-10 | 1988-04-21 | Sachse Hans E | CONDOM CATHETER, A URINE TUBE CATHETER FOR PREVENTING RISING INFECTIONS |
JPS63135179A (en) | 1986-11-26 | 1988-06-07 | 立花 俊郎 | Subcataneous drug administration set |
GB8628564D0 (en) | 1986-11-28 | 1987-01-07 | Smiths Industries Plc | Anti-foaming agent suction apparatus |
GB8706116D0 (en) | 1987-03-14 | 1987-04-15 | Smith & Nephew Ass | Adhesive dressings |
US4787888A (en) | 1987-06-01 | 1988-11-29 | University Of Connecticut | Disposable piezoelectric polymer bandage for percutaneous delivery of drugs and method for such percutaneous delivery (a) |
US4863449A (en) | 1987-07-06 | 1989-09-05 | Hollister Incorporated | Adhesive-lined elastic condom cathether |
US5176663A (en) | 1987-12-02 | 1993-01-05 | Pal Svedman | Dressing having pad with compressibility limiting elements |
US4906240A (en) | 1988-02-01 | 1990-03-06 | Matrix Medica, Inc. | Adhesive-faced porous absorbent sheet and method of making same |
US4985019A (en) | 1988-03-11 | 1991-01-15 | Michelson Gary K | X-ray marker |
GB8812803D0 (en) | 1988-05-28 | 1988-06-29 | Smiths Industries Plc | Medico-surgical containers |
US4919654A (en) | 1988-08-03 | 1990-04-24 | Kalt Medical Corporation | IV clamp with membrane |
US5000741A (en) | 1988-08-22 | 1991-03-19 | Kalt Medical Corporation | Transparent tracheostomy tube dressing |
US5059596A (en) | 1989-01-16 | 1991-10-22 | Roussel Uclaf | Azabicyclo compounds |
GB8906100D0 (en) | 1989-03-16 | 1989-04-26 | Smith & Nephew | Laminates |
US4969880A (en) | 1989-04-03 | 1990-11-13 | Zamierowski David S | Wound dressing and treatment method |
US5261893A (en) | 1989-04-03 | 1993-11-16 | Zamierowski David S | Fastening system and method |
US5100396A (en) | 1989-04-03 | 1992-03-31 | Zamierowski David S | Fluidic connection system and method |
US5527293A (en) | 1989-04-03 | 1996-06-18 | Kinetic Concepts, Inc. | Fastening system and method |
JP2719671B2 (en) | 1989-07-11 | 1998-02-25 | 日本ゼオン株式会社 | Wound dressing |
US5358494A (en) | 1989-07-11 | 1994-10-25 | Svedman Paul | Irrigation dressing |
US5232453A (en) | 1989-07-14 | 1993-08-03 | E. R. Squibb & Sons, Inc. | Catheter holder |
GB2235877A (en) | 1989-09-18 | 1991-03-20 | Antonio Talluri | Closed wound suction apparatus |
US5134994A (en) | 1990-02-12 | 1992-08-04 | Say Sam L | Field aspirator in a soft pack with externally mounted container |
US5092858A (en) | 1990-03-20 | 1992-03-03 | Becton, Dickinson And Company | Liquid gelling agent distributor device |
JP2941918B2 (en) | 1990-09-19 | 1999-08-30 | テルモ株式会社 | Weighing device |
AU650575B2 (en) | 1990-09-25 | 1994-06-23 | Morrison-Knudsen Company, Inc. | Transit car door system and operation |
US5149331A (en) | 1991-05-03 | 1992-09-22 | Ariel Ferdman | Method and device for wound closure |
US5278100A (en) | 1991-11-08 | 1994-01-11 | Micron Technology, Inc. | Chemical vapor deposition technique for depositing titanium silicide on semiconductor wafers |
US5645081A (en) | 1991-11-14 | 1997-07-08 | Wake Forest University | Method of treating tissue damage and apparatus for same |
US5636643A (en) | 1991-11-14 | 1997-06-10 | Wake Forest University | Wound treatment employing reduced pressure |
US5279550A (en) | 1991-12-19 | 1994-01-18 | Gish Biomedical, Inc. | Orthopedic autotransfusion system |
US5167613A (en) | 1992-03-23 | 1992-12-01 | The Kendall Company | Composite vented wound dressing |
FR2690617B1 (en) | 1992-04-29 | 1994-06-24 | Cbh Textile | TRANSPARENT ADHESIVE DRESSING. |
DE4306478A1 (en) | 1993-03-02 | 1994-09-08 | Wolfgang Dr Wagner | Drainage device, in particular pleural drainage device, and drainage method |
US5342376A (en) | 1993-05-03 | 1994-08-30 | Dermagraphics, Inc. | Inserting device for a barbed tissue connector |
US6241747B1 (en) | 1993-05-03 | 2001-06-05 | Quill Medical, Inc. | Barbed Bodily tissue connector |
US5344415A (en) | 1993-06-15 | 1994-09-06 | Deroyal Industries, Inc. | Sterile system for dressing vascular access site |
US5437651A (en) | 1993-09-01 | 1995-08-01 | Research Medical, Inc. | Medical suction apparatus |
US5549584A (en) | 1994-02-14 | 1996-08-27 | The Kendall Company | Apparatus for removing fluid from a wound |
US5607388A (en) | 1994-06-16 | 1997-03-04 | Hercules Incorporated | Multi-purpose wound dressing |
US5556375A (en) | 1994-06-16 | 1996-09-17 | Hercules Incorporated | Wound dressing having a fenestrated base layer |
US5664270A (en) | 1994-07-19 | 1997-09-09 | Kinetic Concepts, Inc. | Patient interface system |
DE69505545T2 (en) | 1994-08-22 | 1999-03-11 | Kinetic Concepts Inc | WOUND DRAINAGE DEVICE |
DE29504378U1 (en) | 1995-03-15 | 1995-09-14 | Mtg Medizinisch Tech Geraeteba | Electronically controlled low-vacuum pump for chest and wound drainage |
GB9523253D0 (en) | 1995-11-14 | 1996-01-17 | Mediscus Prod Ltd | Portable wound treatment apparatus |
US6135116A (en) | 1997-07-28 | 2000-10-24 | Kci Licensing, Inc. | Therapeutic method for treating ulcers |
AU755496B2 (en) | 1997-09-12 | 2002-12-12 | Kci Licensing, Inc. | Surgical drape and suction head for wound treatment |
GB9719520D0 (en) | 1997-09-12 | 1997-11-19 | Kci Medical Ltd | Surgical drape and suction heads for wound treatment |
US6071267A (en) | 1998-02-06 | 2000-06-06 | Kinetic Concepts, Inc. | Medical patient fluid management interface system and method |
US6458109B1 (en) | 1998-08-07 | 2002-10-01 | Hill-Rom Services, Inc. | Wound treatment apparatus |
US6488643B1 (en) | 1998-10-08 | 2002-12-03 | Kci Licensing, Inc. | Wound healing foot wrap |
US6287316B1 (en) | 1999-03-26 | 2001-09-11 | Ethicon, Inc. | Knitted surgical mesh |
US7799004B2 (en) | 2001-03-05 | 2010-09-21 | Kci Licensing, Inc. | Negative pressure wound treatment apparatus and infection identification system and method |
US6856821B2 (en) | 2000-05-26 | 2005-02-15 | Kci Licensing, Inc. | System for combined transcutaneous blood gas monitoring and vacuum assisted wound closure |
US6991643B2 (en) | 2000-12-20 | 2006-01-31 | Usgi Medical Inc. | Multi-barbed device for retaining tissue in apposition and methods of use |
EP1257313B1 (en) | 2000-02-24 | 2004-05-12 | Venetec International, Inc. | Universal catheter anchoring system |
US6855135B2 (en) * | 2000-11-29 | 2005-02-15 | Hill-Rom Services, Inc. | Vacuum therapy and cleansing dressing for wounds |
US7070584B2 (en) * | 2001-02-20 | 2006-07-04 | Kci Licensing, Inc. | Biocompatible wound dressing |
US6540705B2 (en) | 2001-02-22 | 2003-04-01 | Core Products International, Inc. | Ankle brace providing upper and lower ankle adjustment |
US7645269B2 (en) * | 2001-04-30 | 2010-01-12 | Kci Licensing, Inc. | Gradient wound treatment system and method |
GB2382305B (en) * | 2001-11-23 | 2004-12-15 | Johnson & Johnson Medical Ltd | Absorbent wound dressings containing a hydrogel layer |
CA2495385A1 (en) * | 2002-08-21 | 2004-03-04 | Hill-Rom Services, Inc. | Wound packing for preventing wound closure |
US7846141B2 (en) | 2002-09-03 | 2010-12-07 | Bluesky Medical Group Incorporated | Reduced pressure treatment system |
GB0224986D0 (en) | 2002-10-28 | 2002-12-04 | Smith & Nephew | Apparatus |
US6951553B2 (en) * | 2002-12-31 | 2005-10-04 | Kci Licensing, Inc | Tissue closure treatment system and method with externally-applied patient interface |
US7976519B2 (en) | 2002-12-31 | 2011-07-12 | Kci Licensing, Inc. | Externally-applied patient interface system and method |
CA2531248C (en) | 2003-07-22 | 2013-09-17 | Kci Licensing, Inc. | Negative pressure wound treatment dressing |
GB0325130D0 (en) * | 2003-10-28 | 2003-12-03 | Smith & Nephew | Apparatus with scaffold |
GB0325120D0 (en) | 2003-10-28 | 2003-12-03 | Smith & Nephew | Apparatus with actives |
GB0325126D0 (en) | 2003-10-28 | 2003-12-03 | Smith & Nephew | Apparatus with heat |
US8062272B2 (en) | 2004-05-21 | 2011-11-22 | Bluesky Medical Group Incorporated | Flexible reduced pressure treatment appliance |
US7909805B2 (en) | 2004-04-05 | 2011-03-22 | Bluesky Medical Group Incorporated | Flexible reduced pressure treatment appliance |
US8529548B2 (en) | 2004-04-27 | 2013-09-10 | Smith & Nephew Plc | Wound treatment apparatus and method |
WO2006059893A1 (en) | 2004-12-01 | 2006-06-08 | Tarsus Participatie Maatschappij | System for treating a wound |
US7608066B2 (en) | 2005-08-08 | 2009-10-27 | Innovative Therapies, Inc. | Wound irrigation device pressure monitoring and control system |
DE102006017194B4 (en) * | 2006-04-12 | 2010-11-04 | Birgit Riesinger | Fluid-permeable primary dressing |
AU2007319939B2 (en) * | 2006-11-09 | 2013-07-18 | Kci Licensing Inc. | Porous bioresorbable linked dressing comprising microspheres and methods of making same |
EP2125093A4 (en) | 2007-02-21 | 2015-01-21 | Bard Inc C R | Acs therapy system |
DE102008020553A1 (en) * | 2007-04-29 | 2008-10-30 | Iskia Gmbh & Co.Kg | Flat drainage for wound treatment |
JP2010525873A (en) * | 2007-05-01 | 2010-07-29 | ザ ブライハム アンド ウイメンズ ホスピタル, インコーポレイテッド | Wound healing device |
US20090099519A1 (en) | 2007-09-07 | 2009-04-16 | Albert Einstein Healthcare Network | Advanced abdominal dressing for the treatment of the postoperative hypothermic patients with an open abdomen |
WO2009089016A1 (en) * | 2008-01-08 | 2009-07-16 | Southeastern Medical Technologies, Llc | A methods and apparatuses for the treatment of wounds with pressures altered from atmospheric |
WO2009111655A2 (en) * | 2008-03-05 | 2009-09-11 | Kcl Licensing Inc. | Dressing and method for applying reduced pressure to and collecting and storing fluid from a tissue site |
US8021347B2 (en) | 2008-07-21 | 2011-09-20 | Tyco Healthcare Group Lp | Thin film wound dressing |
US8007481B2 (en) | 2008-07-17 | 2011-08-30 | Tyco Healthcare Group Lp | Subatmospheric pressure mechanism for wound therapy system |
WO2009158123A2 (en) | 2008-05-30 | 2009-12-30 | Kci Licensing, Inc. | Reduced-pressure, compression systems and apparatuses for use on breast tissue |
DK2309961T3 (en) * | 2008-08-08 | 2018-03-12 | Smith & Nephew Inc | Wound dressing of continuous fibers |
US8251979B2 (en) | 2009-05-11 | 2012-08-28 | Tyco Healthcare Group Lp | Orientation independent canister for a negative pressure wound therapy device |
US8216198B2 (en) | 2009-01-09 | 2012-07-10 | Tyco Healthcare Group Lp | Canister for receiving wound exudate in a negative pressure therapy system |
CA2734961C (en) | 2008-09-18 | 2014-11-18 | Kci Licensing, Inc. | Therapy delivery systems and methods |
BRPI0913543A2 (en) * | 2008-09-18 | 2019-09-24 | Kci Licensing Inc | reduced pressure treatment system, reduced pressure distributor for applying reduced pressure treatment to a tissue site, distributor for applying reduced pressure treatment to a subcutaneous tissue site, and method for applying reduced pressure to a tissue site |
EP2361069B1 (en) | 2008-11-07 | 2018-12-26 | KCI Licensing, Inc. | Reduced-pressure, wound-treatment dressings and systems |
MX2011005075A (en) * | 2008-11-14 | 2011-05-25 | Kci Licensing Inc | Fluid pouch, system, and method for storing fluid from a tissue site. |
JP5555254B2 (en) * | 2008-12-30 | 2014-07-23 | ケーシーアイ ライセンシング インコーポレイテッド | Apparatus, system, and method for managing liquid flow for use in a tissue site in the presence of reduced pressure |
DE102009019646B4 (en) | 2009-04-30 | 2015-04-30 | Lohmann & Rauscher Gmbh | Wound covering and method of manufacture |
MX2009007258A (en) | 2009-07-03 | 2011-01-24 | Monterrey Inst Tecnologico Y De Estudios Superiores De | Suction compress. |
-
2011
- 2011-03-08 US US13/043,315 patent/US8721606B2/en active Active
- 2011-03-09 JP JP2012557219A patent/JP5972799B2/en active Active
- 2011-03-09 AU AU2011224365A patent/AU2011224365B2/en active Active
- 2011-03-09 CN CN201180011464.7A patent/CN102781380B/en active Active
- 2011-03-09 EP EP11708963.1A patent/EP2544640B1/en active Active
- 2011-03-09 WO PCT/US2011/027761 patent/WO2011112724A1/en active Application Filing
- 2011-03-09 EP EP21201383.3A patent/EP4026525A1/en not_active Withdrawn
- 2011-03-09 CA CA2789000A patent/CA2789000C/en active Active
- 2011-03-11 TW TW100108426A patent/TW201200176A/en unknown
-
2014
- 2014-03-31 US US14/230,487 patent/US9642953B2/en active Active
-
2015
- 2015-12-30 AU AU2015282371A patent/AU2015282371B2/en active Active
-
2016
- 2016-07-13 JP JP2016138111A patent/JP6325026B2/en active Active
-
2017
- 2017-03-08 AU AU2017201597A patent/AU2017201597B2/en active Active
- 2017-04-04 US US15/479,013 patent/US10729590B2/en active Active
-
2019
- 2019-06-26 AU AU2019204514A patent/AU2019204514A1/en not_active Abandoned
-
2020
- 2020-06-24 US US16/910,421 patent/US20200315854A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040030304A1 (en) * | 2000-05-09 | 2004-02-12 | Kenneth Hunt | Abdominal wound dressing |
US20100106115A1 (en) * | 2008-10-29 | 2010-04-29 | Ian Hardman | Open-cavity, reduced-pressure treatment devices and systems |
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11628093B2 (en) | 2008-05-08 | 2023-04-18 | Convatec Technologies, Inc. | Wound dressing |
US11458044B2 (en) | 2008-09-29 | 2022-10-04 | Convatec Technologies Inc. | Wound dressing |
US11135315B2 (en) | 2010-11-30 | 2021-10-05 | Convatec Technologies Inc. | Composition for detecting biofilms on viable tissues |
US11241525B2 (en) | 2010-12-08 | 2022-02-08 | Convatec Technologies Inc. | Wound exudate monitor accessory |
US11116884B2 (en) | 2010-12-08 | 2021-09-14 | Convatec Technologies Inc. | Integrated system for assessing wound exudates |
US11583430B2 (en) | 2011-09-02 | 2023-02-21 | Convatec Ltd. | Skin contact material |
US11241339B2 (en) | 2011-11-29 | 2022-02-08 | Convatec Inc. | Perforated binder for laminated wound dressing |
US10968543B2 (en) | 2011-12-01 | 2021-04-06 | Convatec Technologies Inc. | Wound dressing for use in vacuum therapy |
US11286601B2 (en) | 2012-12-20 | 2022-03-29 | Convatec Technologies, Inc. | Processing of chemically modified cellulosic fibres |
US11723808B2 (en) | 2016-03-30 | 2023-08-15 | Convatec Technologies Inc. | Detecting microbial infections in wounds |
US11740241B2 (en) | 2016-03-30 | 2023-08-29 | Synovo Gmbh | Construct including an anchor, an enzyme recognition site and an indicator region for detecting microbial infection in wounds |
US11266774B2 (en) | 2016-07-08 | 2022-03-08 | Convatec Technologies Inc. | Fluid collection apparatus |
US11452808B2 (en) | 2016-07-08 | 2022-09-27 | Convatec Technologies Inc. | Fluid flow sensing |
US11596554B2 (en) | 2016-07-08 | 2023-03-07 | Convatec Technologies Inc. | Flexible negative pressure system |
US11331221B2 (en) | 2019-12-27 | 2022-05-17 | Convatec Limited | Negative pressure wound dressing |
US11771819B2 (en) | 2019-12-27 | 2023-10-03 | Convatec Limited | Low profile filter devices suitable for use in negative pressure wound therapy systems |
Also Published As
Publication number | Publication date |
---|---|
US20110224631A1 (en) | 2011-09-15 |
JP5972799B2 (en) | 2016-08-17 |
CN102781380A (en) | 2012-11-14 |
JP2016221298A (en) | 2016-12-28 |
US10729590B2 (en) | 2020-08-04 |
AU2019204514A1 (en) | 2019-07-18 |
US20150025484A1 (en) | 2015-01-22 |
US9642953B2 (en) | 2017-05-09 |
JP6325026B2 (en) | 2018-05-16 |
AU2011224365A1 (en) | 2012-08-23 |
EP2544640B1 (en) | 2021-11-10 |
CA2789000A1 (en) | 2011-09-15 |
AU2015282371B2 (en) | 2016-12-15 |
TW201200176A (en) | 2012-01-01 |
AU2017201597B2 (en) | 2019-04-18 |
US20170231824A1 (en) | 2017-08-17 |
AU2011224365B2 (en) | 2015-10-01 |
US8721606B2 (en) | 2014-05-13 |
JP2013521886A (en) | 2013-06-13 |
AU2017201597A1 (en) | 2017-03-30 |
EP4026525A1 (en) | 2022-07-13 |
CN102781380B (en) | 2015-06-03 |
WO2011112724A1 (en) | 2011-09-15 |
EP2544640A1 (en) | 2013-01-16 |
CA2789000C (en) | 2019-01-08 |
AU2015282371A1 (en) | 2016-01-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20200315854A1 (en) | Dressings, systems and methods for treating a tissue site | |
US20200338246A1 (en) | Abdominal treatment systems, delivery devices, and methods | |
US11246758B2 (en) | Open-cavity, reduced-pressure treatment devices and systems |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: KCI LICENSING, INC., TEXAS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:SIMMONS, TYLER;SAMMONS, ALEXANDER;REEL/FRAME:053037/0283 Effective date: 20100517 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |